Category: Health

MIL-OSI USA: Warner & Kaine Call on GOP to Drop Health Care Cuts that will Saddle More Working Families with Medical Debt

US Senate News:

Source: United States Senator for Commonwealth of Virginia Mark R Warner

WASHINGTON – U.S. Sens. Mark R. Warner and Tim Kaine (both D-VA) today urged their colleagues to reject proposed Republican Medicaid cuts that are projected to inflict severe harm on millions of families, citing a new analysis estimating that the GOP’s plans to slash health care would push 5.4 million people – including 2.2 million people currently on Medicaid and 3.2 million people with coverage through the Affordable Care Act – into medical debt and increase the total medical debt that Americans owe by $50 billion – a 15 percent jump.

“Health coverage is prevention. It’s not just treating illness; it’s protecting families from financial ruin. Republicans are trying to gut Medicaid to give tax breaks to the wealthy, and working families will pay the price with their health, their homes, and their financial futures. We should be focused on expanding access to health care and lowering costs, not ripping coverage away and sticking people with thousands of dollars in new debt. We’re calling on our Republican colleagues to drop this dangerous proposal before it’s too late,” said the senators.

Recent analysis published by Third Way, a centrist think tank, found that families losing coverage because of the Republican health care cuts could see their medical debt increase by as much as $22,800. The analysis found that, if the GOP plan is enacted, 107,001 more people in Virginia will be saddled with medical debt, and the amount of medical debt across Virginia would increase by $1,001,789,466.

Medical debt already affects 100 million people in the U.S., amounting to $269 billion in unpaid medical bills. According to a recent Gallup survey, 31 million Americans report having to borrow nearly $74 billion between 2023 and 2024 to pay for health care, and 58 percent of Americans believe they would experience medical debt if faced with a health event. Despite that, Republicans in Congress are pushing a package that, if enacted, will impose the largest cuts to health care in U.S. history and lead to 16 million people in the U.S. losing health insurance coverage.

Sens. Warner and Kaine have been sounding the alarm about the effects of the GOP plan on Virginia families if Republicans in Congress continue to insist on gutting vital programs in order to pay for tax breaks for the richest Americans, noting that the GOP bill would strip health insurance from more than 302,000 Virginians, cut SNAP benefits, raise energy costs for Virginia households, jeopardize more than 20,000 Virginia jobs, raise taxes on minimum wage workers while giving the richest 0.1% a $188,000 tax cut, make tax filing more expensive, explode the deficit, and devastate rural communities.

MIL OSI USA News –

June 24, 2025
MIL-OSI United Nations: Advancing Cancer Care in Niger

Source: International Atomic Energy Agency (IAEA)

In May 2025, IAEA Director General Rafael Mariano Grossi visited Niger’s only radiotherapy centre, CNLC, in Niamey, accompanied by Minister of Public Health Garba Hakimi, Shaukat Abdulrazak, Director of the IAEA’s Division for Africa, and other senior government officials.

Cancer is a growing healthcare challenge in Niger, with over 11 000 new cases and more than 8800 cancer related deaths reported in 2022. Radiotherapy — a treatment needed in nearly half of all cancer cases — remains in short supply in the country, and even those who can afford access to it are let down by out-of-date equipment.

Through its Rays of Hope initiative, the IAEA is supporting efforts to strengthen radiotherapy services in Niger, aiming to expand access to cancer care where it is needed most.

Through the initiative, the IAEA supported Niger in establishing a new cancer treatment facility with state-of-the-art equipment including medical linear accelerator (LINAC), a computed tomography-simulator, an advanced treatment planning system, dosimetry equipment and related accessories.

The new equipment will help expand services for radiotherapy at Niger’s only public radiotherapy centre, which serves a population of 24 million people. Medical professionals will be able to treat tumours more accurately through the country’s new equipment, while sparing normal tissues and critical organs. More Nigerien cancer patients can also be treated locally without having to travel abroad for care.

“The presence of this machinery in our country will significantly enhance the quality of life for the people of Niger, as it will lead to a considerable decrease in treatment costs and medical evacuations”, said Abdourahamane Tchiani President of Niger.

MIL OSI United Nations News –

June 24, 2025
MIL-OSI Security: Florida Nonprofit Founder and Accountant Charged with Stealing Over $100 Million From Special Needs Victims

Source: US FBI

Tampa, FL – United States Attorney Gregory W. Kehoe announces the unsealing of an indictment charging Leo John Govoni (67, Clearwater) and John Leo Witeck (60, Tampa) in connection with a fraud scheme that involved stealing more than $100 million from, and ultimately bankrupting, a non-profit organization in Clearwater that managed funds for vulnerable individuals with special needs and disabilities.

Govoni and Witeck are charged with one count of conspiracy to commit wire and mail fraud, three counts of mail fraud, six counts of wire fraud, and one count of conspiracy to commit money laundering. Govoni is also charged separately with one count of bank fraud, one count of illegal monetary transaction, and one count of making a false bankruptcy declaration. The bank fraud offense carries a maximum penalty of 30 years in prison. Each count of wire fraud, mail fraud, conspiracy to commit wire and mail fraud, and the money laundering conspiracy offense carries a maximum penalty of 20 years’ imprisonment. The illegal monetary transaction count carries a maximum penalty of 10 years in federal prison and the false bankruptcy declaration carries a maximum penalty of 5 years’ imprisonment.

According to the indictment and court documents, around the year 2000, Govoni co-founded the Center for Special Needs Trust Administration (CSNT), a non-profit that managed funds for individuals with disabilities and other special needs, including those who received settlements, court awards, and other payments. CSNT grew to be one of the largest administrators of special needs trusts in the country, with beneficiaries located in Florida and nationwide. As of February 2024, CSNT managed more than 2,100 special needs trusts containing approximately $200 million in assets.

As alleged in the indictment, from June 2009 through May 2025, Govoni, Witeck, and their co-conspirators solicited, stole, and misappropriated CSNT client-beneficiary funds—which they treated as a slush fund to enrich themselves and others—and concealed their illegal activities through complex financial transactions and deceit, including sending fraudulent account statements with false balances to disabled victims and their families. Govoni allegedly used stolen money to purchase real estate, travel via private jet, fund a brewery, make deposits in his personal bank accounts, and pay debts. In February 2024, CSNT filed for bankruptcy and disclosed that more than $100 million in client-beneficiary funds was missing from its trust accounts.

Govoni is also charged with bank fraud related to a $3 million mortgage refinance loan and the alleged laundering of $205,054 of the fraud proceeds to pay off a home equity line of credit on his residence. Govoni is further alleged to have made false declarations to the bankruptcy court related to the CSNT bankruptcy proceedings.

“Protecting the most vulnerable members of our society is a priority of the U.S. Attorney’s Office,” said U. S. Attorney Gregory W. Kehoe for the Middle District of Florida. “The fraud alleged in this nationwide scheme is unfathomable. Due to the diligence and interagency collaboration by our dedicated law enforcement partners, these crimes will be prosecuted to the fullest extent of the law.”

“The subjects charged are accused of creating a slush fund to divert millions of dollars away from a nonprofit organization helping people with special needs,” said Assistant Director Jose A. Perez of the FBI Criminal Investigative Division. “Not only were the organization’s resources drained, but the accused subjects betrayed the trust of the community and ultimately bankrupted a lifeline for vulnerable families. The FBI will not tolerate the exploitation of charitable missions for personal enrichment.”

“The scale and audacity of the alleged fraud in this case are deeply troubling,” said Criminal Investigation Chief Guy Ficco of the IRS. “Stealing funds intended to protect and support people with special needs is as cruel as it is criminal. IRS-CI special agents are dedicated to uncovering complex financial schemes, especially those that prey on the most vulnerable in our society.”

“The defendant disrupted access to critical services for individuals with disabilities and defrauded federal health care programs with the sole purpose of financing a life of extravagance,” stated Deputy Inspector General for Investigations Christian J. Schrank of the U. S. Department of Health and Human Services Office of Inspector General (HHS-OIG). “HHS-OIG, in collaboration with our law enforcement partners, will continue to hold those who’s illicit actions seek to assail enrollees and the nation’s federal health care programs fully accountable.”

An indictment is merely a formal charge that a defendant has committed one or more violations of federal criminal law, and every defendant is presumed innocent unless, and until, proven guilty.

This case was investigated by the Federal Bureau of Investigation, the Internal Revenue Service – Criminal Investigation, the U.S. Department of Health and Human Services – Office of Inspector General, and the Social Security Administration – Office of the Inspector General. It will be prosecuted by Assistant United States Attorneys Jennifer Peresie and Michael Gordon and Department of Justice Trial Attorney Lyndie Freeman of the Criminal Division’s Fraud Section.

MIL Security OSI –

June 24, 2025
MIL-OSI Security: Florida Nonprofit Founder and Accountant Charged with Stealing Over $100 Million From Special Needs Victims

Source: US FBI

Tampa, FL – United States Attorney Gregory W. Kehoe announces the unsealing of an indictment charging Leo John Govoni (67, Clearwater) and John Leo Witeck (60, Tampa) in connection with a fraud scheme that involved stealing more than $100 million from, and ultimately bankrupting, a non-profit organization in Clearwater that managed funds for vulnerable individuals with special needs and disabilities.

Govoni and Witeck are charged with one count of conspiracy to commit wire and mail fraud, three counts of mail fraud, six counts of wire fraud, and one count of conspiracy to commit money laundering. Govoni is also charged separately with one count of bank fraud, one count of illegal monetary transaction, and one count of making a false bankruptcy declaration. The bank fraud offense carries a maximum penalty of 30 years in prison. Each count of wire fraud, mail fraud, conspiracy to commit wire and mail fraud, and the money laundering conspiracy offense carries a maximum penalty of 20 years’ imprisonment. The illegal monetary transaction count carries a maximum penalty of 10 years in federal prison and the false bankruptcy declaration carries a maximum penalty of 5 years’ imprisonment.

According to the indictment and court documents, around the year 2000, Govoni co-founded the Center for Special Needs Trust Administration (CSNT), a non-profit that managed funds for individuals with disabilities and other special needs, including those who received settlements, court awards, and other payments. CSNT grew to be one of the largest administrators of special needs trusts in the country, with beneficiaries located in Florida and nationwide. As of February 2024, CSNT managed more than 2,100 special needs trusts containing approximately $200 million in assets.

As alleged in the indictment, from June 2009 through May 2025, Govoni, Witeck, and their co-conspirators solicited, stole, and misappropriated CSNT client-beneficiary funds—which they treated as a slush fund to enrich themselves and others—and concealed their illegal activities through complex financial transactions and deceit, including sending fraudulent account statements with false balances to disabled victims and their families. Govoni allegedly used stolen money to purchase real estate, travel via private jet, fund a brewery, make deposits in his personal bank accounts, and pay debts. In February 2024, CSNT filed for bankruptcy and disclosed that more than $100 million in client-beneficiary funds was missing from its trust accounts.

Govoni is also charged with bank fraud related to a $3 million mortgage refinance loan and the alleged laundering of $205,054 of the fraud proceeds to pay off a home equity line of credit on his residence. Govoni is further alleged to have made false declarations to the bankruptcy court related to the CSNT bankruptcy proceedings.

“Protecting the most vulnerable members of our society is a priority of the U.S. Attorney’s Office,” said U. S. Attorney Gregory W. Kehoe for the Middle District of Florida. “The fraud alleged in this nationwide scheme is unfathomable. Due to the diligence and interagency collaboration by our dedicated law enforcement partners, these crimes will be prosecuted to the fullest extent of the law.”

“The subjects charged are accused of creating a slush fund to divert millions of dollars away from a nonprofit organization helping people with special needs,” said Assistant Director Jose A. Perez of the FBI Criminal Investigative Division. “Not only were the organization’s resources drained, but the accused subjects betrayed the trust of the community and ultimately bankrupted a lifeline for vulnerable families. The FBI will not tolerate the exploitation of charitable missions for personal enrichment.”

“The scale and audacity of the alleged fraud in this case are deeply troubling,” said Criminal Investigation Chief Guy Ficco of the IRS. “Stealing funds intended to protect and support people with special needs is as cruel as it is criminal. IRS-CI special agents are dedicated to uncovering complex financial schemes, especially those that prey on the most vulnerable in our society.”

“The defendant disrupted access to critical services for individuals with disabilities and defrauded federal health care programs with the sole purpose of financing a life of extravagance,” stated Deputy Inspector General for Investigations Christian J. Schrank of the U. S. Department of Health and Human Services Office of Inspector General (HHS-OIG). “HHS-OIG, in collaboration with our law enforcement partners, will continue to hold those who’s illicit actions seek to assail enrollees and the nation’s federal health care programs fully accountable.”

An indictment is merely a formal charge that a defendant has committed one or more violations of federal criminal law, and every defendant is presumed innocent unless, and until, proven guilty.

This case was investigated by the Federal Bureau of Investigation, the Internal Revenue Service – Criminal Investigation, the U.S. Department of Health and Human Services – Office of Inspector General, and the Social Security Administration – Office of the Inspector General. It will be prosecuted by Assistant United States Attorneys Jennifer Peresie and Michael Gordon and Department of Justice Trial Attorney Lyndie Freeman of the Criminal Division’s Fraud Section.

MIL Security OSI –

June 24, 2025
MIL-OSI Security: California Man Pleads Guilty in Connection with Laundering Proceeds of $16M Hospice Fraud Scheme

Source: United States Attorneys General 1

A California man pleaded guilty today to laundering more than $4.6 million in connection with a years-long scheme to defraud Medicare of nearly $16 million through sham hospice companies.

According to court documents, Mihran Panosyan, 46, of Winnetka, worked with others to launder the proceeds of a massive Medicare fraud scheme, transferring the fraudulently obtained funds between multiple accounts before spending them. The scheme comprised three parts. First, three of Panosyan’s co-defendants used the identities of foreign nationals no longer in the United States to operate several sham hospice companies. Panosyan and his co-defendants maintained fraudulent identification documents, bank accounts, checkbooks, and credit and debit cards in the names of purported foreign owners. Second, the co-defendants caused the submission of false and fraudulent claims to Medicare for hospice services for patients who were not terminally ill and who never requested nor received hospice services. As a result, Medicare paid the sham hospices nearly $16 million. Third, Panosyan and his co-defendants laundered the proceeds of the scheme to conceal the source of the funds and their control over them. Panosyan transferred proceeds of the Medicare fraud between accounts in the names of the purported foreign owners, the sham hospices, and other shell corporations, laundering more than $4.6 million in fraudulently obtained funds that he used to purchase real estate, pay for private school for his minor child, and pay for other personal expenses.

Panosyan pleaded guilty to money laundering and is scheduled to be sentenced on Sept. 8. He faces a maximum penalty of 20 years in prison. A federal district court judge will determine any sentence after considering the U.S. Sentencing Guidelines and other statutory factors.

Panosyan’s co-defendant, Petros Fichidzhyan, previously pleaded guilty to health care fraud, aggravated identity theft, and money laundering. Last month, Fichidzhyan was sentenced to 12 years in prison. Trial against the other three defendants in this case is scheduled to begin July 29.

The guilty plea today is the most recent conviction in the Justice Department’s ongoing effort to combat hospice fraud in the greater Los Angeles area. Last year, a doctor was convicted at trial for his role in a scheme to bill Medicare for hospice services patients did not need, and two other defendants were sentenced for their roles in a hospice fraud scheme.

Matthew R. Galeotti, Head of the Justice Department’s Criminal Division, Assistant Director in Charge Akil Davis of the FBI Los Angeles Field Office, and Acting Special Agent in Charge Omar Pérez Aybar of the Department of Health and Human Services Office of Inspector General (HHS-OIG) Los Angeles Regional Office made the announcement.

The FBI and HHS-OIG are investigating the case.

Trial Attorneys Michael Bacharach, Sarah E. Edwards, and Allison L. McGuire of the Criminal Division’s Fraud Section are prosecuting the case, and Assistant U.S. Attorney Tara B. Vavere of the U.S. Attorney’s Office for the Central District of California is handling asset forfeiture.

The Fraud Section leads the Criminal Division’s efforts to combat health care fraud through the Health Care Fraud Strike Force Program. Since March 2007, this program, currently comprised of 9 strike forces operating in 27 federal districts, has charged more than 5,800 defendants who collectively have billed federal health care programs and private insurers more than $30 billion. In addition, the Centers for Medicare & Medicaid Services, working in conjunction with HHS-OIG, are taking steps to hold providers accountable for their involvement in health care fraud schemes. More information can be found at www.justice.gov/criminal-fraud/health-care-fraud-unit.

An indictment is merely an allegation. All defendants are presumed innocent until proven guilty beyond a reasonable doubt in a court of law.

MIL Security OSI –

June 24, 2025
MIL-OSI Security: California Man Pleads Guilty in Connection with Laundering Proceeds of $16M Hospice Fraud Scheme

Source: United States Attorneys General 1

A California man pleaded guilty today to laundering more than $4.6 million in connection with a years-long scheme to defraud Medicare of nearly $16 million through sham hospice companies.

According to court documents, Mihran Panosyan, 46, of Winnetka, worked with others to launder the proceeds of a massive Medicare fraud scheme, transferring the fraudulently obtained funds between multiple accounts before spending them. The scheme comprised three parts. First, three of Panosyan’s co-defendants used the identities of foreign nationals no longer in the United States to operate several sham hospice companies. Panosyan and his co-defendants maintained fraudulent identification documents, bank accounts, checkbooks, and credit and debit cards in the names of purported foreign owners. Second, the co-defendants caused the submission of false and fraudulent claims to Medicare for hospice services for patients who were not terminally ill and who never requested nor received hospice services. As a result, Medicare paid the sham hospices nearly $16 million. Third, Panosyan and his co-defendants laundered the proceeds of the scheme to conceal the source of the funds and their control over them. Panosyan transferred proceeds of the Medicare fraud between accounts in the names of the purported foreign owners, the sham hospices, and other shell corporations, laundering more than $4.6 million in fraudulently obtained funds that he used to purchase real estate, pay for private school for his minor child, and pay for other personal expenses.

Panosyan pleaded guilty to money laundering and is scheduled to be sentenced on Sept. 8. He faces a maximum penalty of 20 years in prison. A federal district court judge will determine any sentence after considering the U.S. Sentencing Guidelines and other statutory factors.

Panosyan’s co-defendant, Petros Fichidzhyan, previously pleaded guilty to health care fraud, aggravated identity theft, and money laundering. Last month, Fichidzhyan was sentenced to 12 years in prison. Trial against the other three defendants in this case is scheduled to begin July 29.

The guilty plea today is the most recent conviction in the Justice Department’s ongoing effort to combat hospice fraud in the greater Los Angeles area. Last year, a doctor was convicted at trial for his role in a scheme to bill Medicare for hospice services patients did not need, and two other defendants were sentenced for their roles in a hospice fraud scheme.

Matthew R. Galeotti, Head of the Justice Department’s Criminal Division, Assistant Director in Charge Akil Davis of the FBI Los Angeles Field Office, and Acting Special Agent in Charge Omar Pérez Aybar of the Department of Health and Human Services Office of Inspector General (HHS-OIG) Los Angeles Regional Office made the announcement.

The FBI and HHS-OIG are investigating the case.

Trial Attorneys Michael Bacharach, Sarah E. Edwards, and Allison L. McGuire of the Criminal Division’s Fraud Section are prosecuting the case, and Assistant U.S. Attorney Tara B. Vavere of the U.S. Attorney’s Office for the Central District of California is handling asset forfeiture.

The Fraud Section leads the Criminal Division’s efforts to combat health care fraud through the Health Care Fraud Strike Force Program. Since March 2007, this program, currently comprised of 9 strike forces operating in 27 federal districts, has charged more than 5,800 defendants who collectively have billed federal health care programs and private insurers more than $30 billion. In addition, the Centers for Medicare & Medicaid Services, working in conjunction with HHS-OIG, are taking steps to hold providers accountable for their involvement in health care fraud schemes. More information can be found at www.justice.gov/criminal-fraud/health-care-fraud-unit.

An indictment is merely an allegation. All defendants are presumed innocent until proven guilty beyond a reasonable doubt in a court of law.

MIL Security OSI –

June 24, 2025
MIL-OSI NGOs: Advancing Cancer Care in Niger

Source: International Atomic Energy Agency (IAEA) –

In May 2025, IAEA Director General Rafael Mariano Grossi visited Niger’s only radiotherapy centre, CNLC, in Niamey, accompanied by Minister of Public Health Garba Hakimi, Shaukat Abdulrazak, Director of the IAEA’s Division for Africa, and other senior government officials.

Cancer is a growing healthcare challenge in Niger, with over 11 000 new cases and more than 8800 cancer related deaths reported in 2022. Radiotherapy — a treatment needed in nearly half of all cancer cases — remains in short supply in the country, and even those who can afford access to it are let down by out-of-date equipment.

Through its Rays of Hope initiative, the IAEA is supporting efforts to strengthen radiotherapy services in Niger, aiming to expand access to cancer care where it is needed most.

Through the initiative, the IAEA supported Niger in establishing a new cancer treatment facility with state-of-the-art equipment including medical linear accelerator (LINAC), a computed tomography-simulator, an advanced treatment planning system, dosimetry equipment and related accessories.

The new equipment will help expand services for radiotherapy at Niger’s only public radiotherapy centre, which serves a population of 24 million people. Medical professionals will be able to treat tumours more accurately through the country’s new equipment, while sparing normal tissues and critical organs. More Nigerien cancer patients can also be treated locally without having to travel abroad for care.

“The presence of this machinery in our country will significantly enhance the quality of life for the people of Niger, as it will lead to a considerable decrease in treatment costs and medical evacuations”, said Abdourahamane Tchiani President of Niger.

MIL OSI NGO –

June 24, 2025
MIL-OSI Africa: Empowering youth, protecting the planet: United Nations Support Office in Somalia (UNSOS) partners with Somali universities to train future environmental advocates

Download logo

Twenty-five students from SIMAD University in Mogadishu were given one day training on the practical management of wastewater and solid waste to help prevent pollution of the environment. The session took place at the UNSOS environmental installations, namely the wastewater treatment plants and waste management yard. This training aimed to equip students with hands-on skills for effective waste handling and environmental protection.

This initiative is spearheaded by the UNSOS Environmental Unit, with the aim of linking theoretical knowledge with practical management of the environment, for the benefit of fourth-year public health students. The initiative directly addresses the practical educational gaps in science, which is critical for Somalia’s environmental protection. “UNSOS is committed to supporting locals through the building the capacity as part of our environmental management system,” says Jama, UNSOS Environmental Affairs Officer.

Since the inception of the program in November 2024, UNSOS has trained 58 undergraduate students in solid waste and wastewater management at the UN facilities in Mogadishu. Jazeera University was the first to partner with UNSOS on this initiative, and it has now been joined by SIMAD University. By collaborating with academic institutions, UNSOS aims to foster a new generation of environmental advocates and professionals who can contribute to Somalia’s environmental protection and public health goals.

“I have learnt a lot that will enhance my experience. I have practically undertaken what I studied in theory, Garbage is not all waste; it includes materials that can be beneficial to the people and the environment, instead of just being dumped around. We can profit from reusable and recyclable materials like plastics, rather than allow them to negatively impact our health and the environment”, said Muna Hassan Warsame, a passionate advocate for environmental change in her final year of Public Health at SIMAD University. =

The students’ first field visit was to a waste management facility, a central hub for waste collected daily from 43 designated points within the UN and African Union Support and Stabilization Mission in Somalia (AUSSOM) compounds. There, they observed the critical segregation process, a routine operation aimed at reducing the volume for final disposal and enhancing recycling efficiency.

Distributed by APO Group on behalf of United Nations Support Office in Somalia (UNSOS).

MIL OSI Africa –

June 24, 2025
MIL-OSI Security: Man Charged for Stabbing Visitor at the Wounded Knee Memorial Site in the Pine Ridge Reservation

Source: US FBI

RAPID CITY – United States Attorney Alison J. Ramsdell announced that the United States Attorney’s Office has charged 18-year-old Raymond Eagle Hawk, Jr., of Wounded Knee, South Dakota, with Assault with Intent to Commit Murder.

On June 12, 2025, Eagle Hawk was intoxicated and panhandling at the Wounded Knee cemetery parking lot. The victim, a 71-year-old man, and his wife had traveled to the Pine Ridge Reservation from their home in Texas to visit the Wounded Knee Memorial site, near Wounded Knee village, within the Pine Ridge Reservation.

At the memorial site, Eagle Hawk asked the victim for money. The victim gave Eagle Hawk a small sum of cash, but Eagle Hawk continued to demand money. When the victim did not give Eagle Hawk more money, Eagle Hawk stabbed him in the throat with a knife. The victim sustained a grievous injury to his neck and attempted to return to his vehicle. Eagle Hawk continued to advance on the victim, but then fled the cemetery. The victim was transported to the Pine Ridge hospital and later flown by air ambulance to Monument Health Hospital in Rapid City, where he underwent emergency surgery to repair the wound to his neck.

Eagle Hawk appeared before U.S. Magistrate Judge Daneta Wollmann on June 18, 2025, and pleaded not guilty to the criminal complaint. Eagle Hawk was remanded to the custody of the U.S. Marshals Service pending a preliminary hearing and a detention hearing, scheduled for June 27, 2025.

The maximum penalty upon conviction is 20 years in custody in a federal prison.

The charge is merely an accusation and Eagle Hawk is presumed innocent until and unless proven guilty.

This matter is being prosecuted by the U.S. Attorney’s Office because the Major Crimes Act, a federal statute, mandates that certain violent crimes alleged to have occurred in Indian Country be prosecuted in Federal court as opposed to State court.

The investigation is being conducted by the Federal Bureau of Investigation and the Oglala Sioux Tribe Department of Public Safety Criminal Investigations Division. Assistant United States Attorney Heather Knox is prosecuting the case.

MIL Security OSI –

June 24, 2025
MIL-OSI: Wellnee Knee Brace 2025: The Wellnee Knee Brace Sets a New Standard in Day-to-Day Knee Support for Aging and Active Populations
Source: GlobeNewswire (MIL-OSI)

New York City, NY, June 23, 2025 (GLOBE NEWSWIRE) — As knee discomfort continues to affect millions globally—particularly among aging adults and active individuals—the search for effective, non-invasive support solutions has reached new heights. In 2025, the Wellnee Knee Brace has emerged as a widely discussed option for daily mobility, rehabilitation, and active lifestyles, drawing interest from wellness professionals and orthopedic communities alike.

Reports suggest that this lightweight, easy-to-wear brace is redefining how people manage knee stability, inflammation, and range of motion—without sacrificing comfort or movement.

Why the Wellnee Knee Brace Is Gaining National Attention

With rising demand for supportive wearables that enhance joint function and reduce the risk of strain or injury, the Wellnee Knee Brace offers a promising approach for both chronic users and preventative wearers.

What makes this brace different?
- Anatomically engineered compression
- Adjustable ergonomic straps
- Flexible yet firm lateral stabilizers
- Breathable, sweat-resistant material for long wear
- Lightweight, discreet design that fits under most clothing
From seniors managing arthritis to athletes recovering from minor ligament stress, the brace is designed to serve a wide audience seeking practical relief and functional stability.

The Engineering Behind Wellnee: Designed for Movement, Built for Support

According to official website, the Wellnee Knee Brace underwent several iterations to perfect the balance between rigidity and flexibility. Its dual-spring support system works in tandem with compression zones that surround the patella and ligaments—offering both lift and alignment without impeding circulation.

“People don’t want bulky braces anymore—they want dynamic stability without losing mobility,” said a representative familiar with the product. “The Wellnee design was built to respond to movement while protecting sensitive areas.”

Who Is the Wellnee Knee Brace For?

The target demographic spans multiple categories:
- Seniors with age-related joint discomfort
- Office workers and remote professionals experiencing stiffness from sedentary routines
- Hikers, runners, and gym-goers seeking joint protection during active use
- Individuals in physical therapy or post-operative recovery
- Those living with arthritis, meniscus tears, or ligament strain
Whether for temporary strain or long-term support, Wellnee offers a modular solution suited to everyday routines—without the commitment of prescriptions or surgeries.

How the Wellnee Knee Brace Aligns with Modern Joint Care Trends

The Wellnee product launch follows a larger industry trend focused on non-invasive, wearable recovery tools. As more consumers seek alternatives to pharmaceuticals and complex medical devices, the demand for affordable, at-home mobility aids is rising.

Healthcare professionals are increasingly recommending compression and stabilization techniques to slow down degeneration and improve proprioception—both of which the Wellnee Knee Brace aims to support.

Visit Official Website To get More Information

How Does the Wellnee Knee Brace Work?

As per official website, Unlike conventional knee braces that simply restrict motion, the Wellnee Knee Brace uses a dynamic stabilization system engineered to support movement—not limit it. This targeted design integrates dual-spring lateral stabilizers that work in harmony with a compression fabric matrix, gently guiding the joint into proper alignment during both motion and rest.

The central patella ring relieves direct kneecap pressure, while the surrounding structure reduces load-bearing strain on surrounding ligaments. This not only eases discomfort from conditions like arthritis or runner’s knee but also enhances joint awareness, helping users walk or move more confidently.

What sets Wellnee apart is its adaptive support—it offers reinforcement when needed most, such as during walking, climbing stairs, or exercising, but flexes enough to stay comfortable throughout the day.

Key Features of the Wellnee Knee Brace

As attention grows toward smart, wearable wellness, the Wellnee Knee Brace stands out with several well-researched features designed around functionality and comfort:
- 360° Stabilizing Support
  Built-in steel springs provide resistance and structure without restricting movement.
- Open-Patella Design
  Reduces kneecap pressure while improving tracking during activity.
- Custom-Fit Compression Zones
  Engineered for graduated support, reducing inflammation and swelling.
- Breathable, Moisture-Wicking Fabric
  Ideal for long hours of wear—even under clothing or in warm environments.
- Fully Adjustable Hook-and-Loop Straps
  One-size-fits-most system with secure tension settings for both casual and athletic use.
- Low-Profile Silhouette
  Sleek enough to wear during everyday errands, long commutes, or light workouts.
Whether supporting injury recovery or easing long-standing discomfort, these features combine to offer stability without stiffness, and support without sacrifice.

How to Use the Wellnee Knee Brace

Part of what’s fueling the buzz around the Wellnee Knee Brace in 2025 is how accessible and simple it is to use—even for those unfamiliar with orthopedic gear.

To get started:
1. Unfold and slide the brace onto the leg, positioning the open patella ring directly over the kneecap.
2. Adjust the compression straps using the built-in hook-and-loop fasteners until you feel balanced support—tight, but not restrictive.
3. Ensure even pressure distribution, with no pinching at the thigh or calf.
4. Wear throughout the day, whether for mobility support, injury prevention, or during periods of prolonged standing or activity.
Most users report adapting to the brace within minutes, and because the material is breathable, it can be comfortably worn for extended periods—whether under clothing at work or during moderate exercise routines.

No complicated setup. No batteries. No prescriptions. Just intuitive, immediate support—whenever and wherever your knees need it most.

Where to Buy the Wellnee Knee Brace

The Wellnee Knee Brace is currently available through the official website.

Buyers can access:
- Single or dual-knee packs
- Adjustable size options
- 30-day satisfaction guarantee
What Experts Are Saying

Orthopedic advisors and fitness trainers are beginning to take note of the design. While the brace is not a replacement for medical-grade orthotics, its everyday wearability has drawn praise.

“Support like this can help people become more active with less pain, especially when paired with stretching and strength routines,” said one physiotherapist based in New York.

Why 2025 May Be the Year of Wearable Joint Solutions

With the average adult spending more than 8 hours a day sitting and millions reporting musculoskeletal pain, wearable joint support is entering the spotlight.

Wellnee’s rise reflects a shift in public interest—where people want results without restrictions, and prevention without prescriptions.

Can the Wellnee Knee Brace Help with Arthritis? Here’s What Users Say

While the Wellnee Knee Brace is not a cure for arthritis, many wearers dealing with osteoarthritis or rheumatoid symptoms have found relief in its compression-based joint unloading. By offering lateral reinforcement and reducing strain on inflamed areas, users often report:
- Better walking confidence
- Reduced swelling after movement
- Decreased reliance on over-the-counter pain relief
For arthritis patients, even slight improvements in day-to-day comfort can translate to greater independence and long-term wellness.

Visit Wellnee Knee Brace Official Website To Read More..

The Rise of Non-Prescription Mobility Aids: A 2025 Trend

A growing number of Americans are now looking beyond pharmaceuticals and surgeries to support joint health. According to recent market trends, non-invasive mobility devices—like the Wellnee Knee Brace—are experiencing a sharp rise in demand.

Why?
- Lower cost
- Fewer risks than injections or surgeries
- Accessibility for aging populations
- Compatibility with daily life and work schedules
This shift signals a larger movement: consumers want natural, supportive solutions that fit their lives, not interrupt them.

Wellnee’s Appeal Across Age Groups: From Office Workers to Weekend Warriors

Though knee support products have long been associated with aging, the demographic profile of users is changing. Younger professionals, fitness enthusiasts, and manual laborers are now prioritizing preventative joint care—long before serious problems arise.

The Wellnee Knee Brace is built to accommodate both:
- Younger users who need light, all-day support during high mobility
- Older adults who want comfort without the bulk or stiffness of medical-grade braces
With universal sizing and a lightweight design, Wellnee bridges the gap between clinical function and everyday wearability.

What to Expect in the First Week of Wearing Wellnee

According to official website, Most first-time users experience immediate support, but full adaptation typically takes a few days. During the initial adjustment period, users often notice:
- A subtle sense of lift or offloading in the joint
- Decreased fatigue after standing or walking
- Improved alignment during activities like stair climbing or squatting
Unlike rigid braces that cause muscle compensation or stiffness, Wellnee works with the body—not against it—resulting in a natural, supported motion pattern.

What Makes Wellnee Different? A Brand Rooted in Movement, Not Limitations

Behind the rise of the Wellnee Knee Brace is a mission that resonates with millions: mobility should be supported, not restricted. In a crowded market of rigid braces, one-size-fits-all sleeves, and clinical-looking supports, Wellnee took a different approach—one that puts user experience, real-world function, and wearability at the core of its design philosophy.

Founded by a team of engineers, wellness advocates, and movement therapists, the Wellnee brand was born from a simple observation: people are living longer, working harder, and staying active well into later stages of life—but joint health tools haven’t kept up.

“We weren’t satisfied with what was available. Most braces were either too bulky to wear all day or too flimsy to offer any real support. We set out to build something in between—something supportive, sleek, and wearable for real people,” said a Wellnee spokesperson.

The result? A knee brace that doesn’t look or feel medical—but performs when it counts.

From Concept to Confidence: A People-First Design Journey

What makes Wellnee different isn’t just what it does—it’s how it was developed. Unlike mass-produced sleeves or cookie-cutter designs, the Wellnee Knee Brace underwent months of prototyping and field testing. Early feedback came from:
- Rehabilitation patients in physical therapy programs
- Aging adults dealing with early-stage arthritis
- Athletes and personal trainers who needed support without stiffness
- Long-hour workers in warehouse, retail, and healthcare roles
Their insight shaped everything from the brace’s compression zones to its strap system and material choices.

Instead of prioritizing mass appeal, Wellnee focused on one metric: will people want to wear this daily?

Visit Official Website To get More Information

Designing for Real Life, Not Just Recovery

While many braces are designed for temporary use after injury, Wellnee supports consistent, everyday function. It’s not just a recovery tool—it’s a companion for movement. Whether navigating grocery aisles, walking to the train, or stretching before a hike, Wellnee blends into daily routines without slowing users down.

This holistic focus on real-life wearability has positioned Wellnee as more than a medical device—it’s a lifestyle product rooted in movement, prevention, and independence.

A Community-Driven Brand Built on Trust

Beyond the product itself, the Wellnee brand has grown through word-of-mouth—from physical therapists to grandparents to fitness instructors. Social media groups and online forums have become platforms for users to share how the brace has helped them walk farther, move easier, and feel more confident on their feet.

Wellnee’s commitment to transparency, user feedback, and accessible support has only strengthened its reputation among consumers looking for practical, long-lasting solutions.

In a space saturated with short-term fixes, Wellnee stands out as a long-term ally—a brand that’s less about restriction and more about restoring confidence, one step at a time.

Final Thoughts: Wellnee’s Place in the Evolving World of Joint Care

As 2025 continues to see innovation across personal health, the Wellnee Knee Brace positions itself as more than a brace—it’s a day-to-day companion for knees that carry us through work, workouts, and everything in between.

From joint relief to post-injury confidence, Wellnee appears to be paving a new path in joint care—one that prioritizes practicality, portability, and personal independence.

For more information, educational content, and direct purchasing, visit the official Wellnee Knee Brace website.

Media Contact:

ADDRESS: 67-04 Myrtle Ave #500,

Glendale, NY

USA 11385

Email: support@trywellnee.com

Phone – +1(844)961-3766

Website – https://trywellnee.com/

Disclaimer The information provided in this review is for general educational and informational purposes only and is not intended as, nor should it be considered a substitute for, professional medical advice, diagnosis, or treatment. Always consult with your physician or another qualified healthcare provider before beginning any new supplement, dietary change, or health program—especially if you are pregnant, nursing, have existing health conditions, or are taking medications. Results may vary among individuals.
The statements made regarding Wellnee Knee Brace have not been evaluated by the Food and Drug Administration (FDA). Wellnee Knee Brace is not intended to diagnose, treat, cure, or prevent any disease. Any claims made within this article about symptom relief, hearing improvement, or related health benefits are based on the product’s formulation and individual testimonials and not on conclusive clinical evidence.
This content does not constitute professional health or medical advice and should not be interpreted as such. Readers should always perform their own due diligence and consult medical professionals before making decisions related to health products.

Attachment
- Wellnee Knee Brace
The MIL Network –
June 24, 2025
MIL-OSI Canada: New brain-injury supportive living home will better support people

Source: Government of Canada regional news

Lana Popham, MLA for Saanich South –

“This supportive living home with a focused model of support will meet the unique needs of people living with acquired brain injuries on Vancouver Island. The opening of Connect Saanich Peninsula represents hope and new opportunities for specialized community-based healing and support closer to home.”

Leah Hollins, board chair, Island Health –

“This new service aligns with Island Health’s goal to provide patient-centred, accessible and equitable care for Vancouver Island residents, and will address an identified gap in specialized brain-injury services on the south Island. By expanding and improving the services provided to people living with brain injuries, we can improve quality of life for clients, provide hope for improved wellness, support families and caregivers and reduce strain on hospitals and long-term care resources.”

Ashley Ormiston, regional program co-ordinator, brain injury program, Island Health –

“Living with a brain injury can be life-altering. With early intervention and focused, timely interventions, we know people with brain injuries can begin to recover, improve their health, gain independence and reintegrate into society.”

Patti Flaherty, CEO, Connect Communities –

“We are thrilled to partner with Island Health and expand Connect’s Life Redesign Model to Vancouver Island. Our team has more than 30 years of experience supporting individuals after brain injury and stroke in Langley, Kelowna and Ontario. Our south-Island location will help empower and coach the people we support to redesign their lives to find meaning and connection.”

MIL OSI Canada News –

June 24, 2025
MIL-OSI Asia-Pac: DH to launch final phase of HPV Vaccination Catch-up Programme on June 26

Source: Hong Kong Government special administrative region

DH to launch final phase of HPV Vaccination Catch-up Programme on June 26???
The Controller of the CHP, Dr Edwin Tsui said, “In Hong Kong, cervical cancer was the ninth most common cancer among women in 2022, with 522 new cases and 167 deaths. The HPV vaccine is highly effective in preventing the high-risk types of HPV that most commonly cause cervical cancer. Following the recommendations of the World Health Organization, the DH launched the first phase of Programme in December last year to provide free vaccination for female full-time students studying in Secondary Five or above (including secondary sections of special schools). As of June 8, the coverage rate for the first dose of the HPV vaccine in the first phase of the Programme has exceeded 80 per cent. The second phase has begun in mid-March this year, offering free HPV vaccination to female Hong Kong residents born between 2004 and 2008 who are currently studying at local post-secondary institutions. All post-secondary institutions have participated.”

Under the final phase of the Programme, all female Hong Kong residents born between 2004 and 2008 who are not currently studying and have not completed their HPV vaccination only need to register with eHealth first, after which they can make an appointment through the website or telephone number of the WWS under the PHCC of the HHB for free vaccination at the WWS and its service points, or designated District Health Centre (DHC)/Express (E). Appointments can be made starting today by calling the WWS at 2855 1333 or through its website (www.wws.org.hk/vaccineIssued at HKT 17:55

NNNN

CategoriesMIL-OSI

MIL OSI Asia Pacific News –

June 24, 2025
MIL-OSI USA: Anesthesia Delivery Systems Recall: GE HealthCare Issues Correction for Certain Carestations due to Risk of Ineffective Ventilation When Used in Volume Control Ventilation (VCV) Mode 

Source: US Department of Health and Human Services – 3

This recall involves correcting certain devices and does not involve removing them from where they are used or sold. The FDA has identified this recall as the most serious type. This device may cause serious injury or death if you continue to use it without correction.
Affected Product
•    Product Names: Carestation 620/650/650c and 750/750c Anesthesia Systems

Full List of Affected Devices

Product

Ref Number

UDI Number

Carestation 620 A1

1012-9620-200

00195278439536

Carestation 650C A1

1012-9655-200

00195278439543

Carestation 650 A1

1012-9650-200

00195278439529

Carestation 620 A1

1012-9620-000

00840682103985

Carestation 650 A1

1012-9650-000

00840682103947

Carestation 650c A1

1012-9655-000

00840682103954

Carestation 620 A2

1012-9620-002

00840682124546

Carestation 650 A2

1012-9650-002

00840682124560

Carestation 650c A2

1012-9655-002

00840682124539

Carestation 650 SE A2

1012-9650-012

00195278569684

Carestation 620 SE A2

1012-9620-012

00195278569677

Carestation 750 A1

1012-9750-000

00840682145596

Carestation 750c A1

1012-9755-000

00840682146425

Carestation 750 A2

1012-9750-002

00840682146470

Carestation 750c A2

1012-9755-002

00840682146463

What to Do
On March 21, 2025, GE HealthCare sent all affected customers an urgent medical device correction notice recommending the following actions:

Ensure users are made aware not to use Volume Control Ventilation (VCV) mode on the device until the device has been corrected by GE HealthCare.
Ensure all potential staff in your facility are made aware of this safety notification and the recommended actions.
Complete and return the Medical Device Notification Acknowledgement Response Form.
Perform the Ventilation Screening Test for each affected Carestation system.

If the Carestation system passes the Ventilation Screening Test, you can continue to use the device in accordance with the instructions in the User Reference Manual (URM).

If the Carestation system fails the Ventilation Screening Test and must be used prior to the system being corrected by GE HealthCare, follow these instructions:

Use the device in accordance with the instructions in the URM with these changes:

Use only Pressure Control Ventilation (PCV) or Pressure Control Ventilation Volume Guarantee (PCV-VG) mode to mechanically ventilate a patient.
Do not use Volume Control Ventilation (VCV) mode to mechanically ventilate a patient.

NOTE: Manual mode of the anesthesia system can be used to provide manual ventilation or allow spontaneous ventilation of the patient.
Reason for Correction
GE HealthCare is correcting certain Carestation devices due to the risk that they may not provide effective ventilation when used in Volume Control Ventilation (VCV) mode. In these systems, effective ventilation can be achieved in Pressure Control Ventilation (PCV) or Pressure Control Ventilation Volume Guarantee (PCV-VG) modes or with manual ventilation. If this issue occurs, it will be apparent to the user through observation and multiple alarms. The inflated bellows, visible through transparent glass, will stop moving and an audible alarm and visual Unable to Drive Bellows message will alert the user. Additional alarms including Apnea, EtCO2 low, MVexp low, RR low, and TVexp low will also alert the user to inadequate ventilation.
The use of affected product may cause serious adverse health consequences, including failure of ventilation resulting in hypoxia (inadequate oxygen levels) and death.
 At this time, GE HealthCare has reported no serious injuries or deaths related to this issue.
Device Use
Intended use of the Carestation is to provide monitored anesthesia care, general inhalation anesthesia and/or ventilatory support to a wide range of patients (neonatal, pediatric, and adult). The anesthesia systems are suitable for use in a patient environment, such as hospitals, surgical centers, or clinics by a clinician qualified in the administration of general anesthesia.
Contact Information
Customers in the U.S. with questions about this recall should contact GE HealthCare Service at 1-800-437-1171.
Additional FDA Resources (listed in order of most to least recent):

Unique Device Identifier (UDI)
The unique device identifier (UDI) helps identify individual medical devices sold in the United States from distribution to use. The UDI allows for more accurate reporting, reviewing, and analyzing of adverse event reports so that devices can be identified more quickly, and as a result, problems potentially resolved more quickly.

How do I report a problem?
Health care professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program.

Content current as of:
06/23/2025

Regulated Product(s)

MIL OSI USA News –

June 24, 2025
MIL-OSI Africa: Food and Agriculture Organization of the United Nations (FAO) and International Plant Protection Convention (IPPC) launch second phase of the Africa Phytosanitary Programme

The Food and Agriculture Organization of the United Nations (FAO) and the International Plant Protection Convention (IPPC), in collaboration with the Government of South Africa, represented by the Department of Agriculture, launched the second phase of the Africa Phytosanitary Programme (APP) today – representing a major effort to stop the spread of plant pests and diseases in Africa using cutting-edge digital tools.

The launch event was hosted by the Government of South Africa and brought together over 50 phytosanitary specialists from nine countries: Algeria, Cape Verde, Chad, the Republic of Congo, Liberia, Malawi, Senegal, South Africa and Tunisia. They will participate in a weeklong Train-the-Trainer (ToT) workshop in advanced pest surveillance techniques, including the use of customised digital tools and applications for monitoring, detecting and reporting major pests of economic, regulatory and environmental importance in Africa. Participants will receive state-of-the-art tablets for geospatial pest surveillance, use field survey protocols developed by technical experts, and undertake practical sessions using the pest survey tools.

“Africa stands at a turning point. With immense biodiversity, rising agricultural productivity, and growing opportunities under the African Continental Free Trade Area (AfCFTA), we are well-positioned to become a global leader in the trade of high-quality plant products. But this vision can only be achieved if we ensure that the movement of plants and plant products is safe, traceable, and fully compliant with international phytosanitary standards” said John Henry Steenhuisen, Honourable Minister of Agriculture, in South Africa, in remarks read on his behalf by Jan Hendrik Venter, South Africa’s Director of Plant Health.

“Well-trained, well-equipped plant health officials across the continent are our best line of defence in maintaining pest-free or low-prevalence status, an essential condition for accessing these lucrative markets”, he added.

The first and pilot phase of APP started in 2023, engaging phytosanitary specialists from Cameroon, Democratic Republic of Congo, Egypt, Guinea-Bissau, Kenya, Mali, Morocco, Sierra Leone, Uganda, Zambia and Zimbabwe. Phase 2 builds on achievements made in the pilot phase and aims to train plant health officers, who upon their return to their countries will teach their peers in the national plant protection organisations (NPPOs) and other government stakeholders on the use of the APP suite of digital tools.

“We are building a critical mass of phytosanitary inspectors, technicians and officers across Africa by equipping plant health officers with the tools and skills to prevent and address major plant pest threats, that ultimately jeopardize food security, agricultural trade, economic growth and the environment”, said Beth Bechdol, FAO Deputy Director-General and Officer-in-Charge of the IPPC, in her video message.

Funded through generous contributions from the European Union and the United Kingdom of Great Britain and Northern Ireland, APP phase two builds on support from the United States Department of Agriculture (USDA), Animal and Plant Health Inspection Service (APHIS) which funded phase one in 2023. FAO and the IPPC are working to replicate and scale up the benefits from APP to more African countries and other regions.

Mitigating the pest problem in Africa

Worldwide, plant pests destroy about 40 percent of crop yields, resulting in approximately USD 220 billion in economic losses[1]. In Africa, the impacts of climate change are worsening the problem, with invasive pests – such as, fruit flies, false codling moth, maize lethal necrosis disease, citrus greening and fall armyworm – causing major damages. Fall armyworm alone is estimated to cause the highest yield loss in Africa – USD 9.4 billion annually –, based on data from the Centre for Agriculture and Bioscience International (CABI).

The African Union’s Plant Health Strategy for Africa highlights that limited technical capability remains a key barrier to achieving sustainable agriculture on the continent. Through APP, FAO, the IPPC and partners aim to strengthen plant health systems and build national phytosanitary capacity across Africa.

Distributed by APO Group on behalf of Food and Agriculture Organization of the United Nations (FAO): Regional Office for Africa.

MIL OSI Africa –

June 24, 2025
MIL-OSI Europe: Answer to a written question – EMA’s role in COVID-19 vaccine approval procedures, inspections and good clinical practice checks – P-001695/2025(ASW)
Source: European Parliament
The highest standards in the evaluation of COVID-19 vaccines were applied by the European Medicines Agency (EMA). As for every other product it evaluates, EMA’s human medicines committee[1] (CHMP) considered the need for good clinical practice (GCP) inspections.

Studies supporting the authorisation of a medicine must comply with GCP. Regulators can request and conduct inspections to verify compliance with the standards.

Criteria used to select a GCP inspection is published[2]. When a GCP inspection is requested by the CHMP, EMA makes a call for available EU national GCP inspection resources.

The Member States have the final say on whether to send inspectors for an EMA-coordinated inspection. During the COVID-19 pandemic, due to the restrictions to travel with a view to protect public health, regulators assessed the need for inspections and decided on a case-by-case basis the most appropriate and viable approach to take.

The European Public Assessment Reports for Vaxzevria[3] and Comirnaty[4] are publicly available.

The first cases of myocarditis that occurred in Israel in 2021 following vaccination with Comirnaty triggered a formal review by EMA[5].

The outcome was that the risk for myocarditis and pericarditis was overall ‘very rare’ (up to one in 10 000 vaccinated people may be affected) with the highest risk in younger males[6].

The product information of Comirnaty and Spikevax was revised adding myocarditis and pericarditis as new side effects with a warning to raise awareness.

[1] https://www.ema.europa.eu/en/committees/committee-medicinal-products-human-use-chmp.

[2] https://www.ema.europa.eu/en/documents/other/points-consider-assessors-inspectors-european-medicines-agency-inspection-coordinators-identification-triggers-selection-applications-routine-cause-inspections-their-investigation-scope-such_en.pdf.

[3] Vaxzevria (previously COVID-19 Vaccine AstraZeneca), INN-COVID-19-Vaccine-(ChAdOx1-S-[recombinant]) https://www.ema.europa.eu/en/documents/assessment-report/vaxzevria-previously-covid-19-vaccine-astrazeneca-epar-public-assessment-report_en.pdf.

[4] https://www.ema.europa.eu/en/documents/assessment-report/comirnaty-epar-public-assessment-report_en.pdf.

[5] https://www.ema.europa.eu/en/documents/report/report-pharmacovigilance-tasks-eu-member-states-and-european-medicines-agency-ema-2019-2022_en.pdf.

[6] Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 29 November — 2 December 2021 https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-29-november-2-december-2021.
Last updated: 23 June 2025
MIL OSI Europe News –
June 24, 2025
MIL-OSI Europe: Answer to a written question – Liability exemptions in EU vaccine contracts – E-001495/2025(ASW)
Source: European Parliament
The (Advanced) Purchase Agreements for the supply of COVID-19 vaccines to the Member States were concluded in full transparency with the Member States. Negotiations were carried out by a Joint Negotiation Team that consisted of representatives of the Commission and of several Member States.

This team reported regularly to a Vaccines Steering Board co-chaired by the Commission and a Participating Member State, which provided guidance throughout the process.

The Commission has provided information to the Parliament on a continuous basis, in line with its Treaty obligations and the framework Agreement on relations between the two institutions[1].

All mRNA vaccines that receive a marketing authorisation are based on a thorough review by the European Medicine Agency (EMA), of clinical evidence confirming a favourable benefit-risk profile.

Adapted versions are also approved based on data showing their ability to induce an immune response that can predict clinical efficacy and safety.

T he safety profile of all medicinal products authorised in the EU, including mRNA vaccines, is subject to continuous monitoring. There is a robust pharmacovigilance system established in the EU to detect, assess, and address potential side effects[2].

The Commission and Member States considered early introduction of the vaccine to be in the interest of public health. Member States were therefore willing to reduce manufacturers’ risks linked to liability for adverse effects[3].

A citizen who has suffered adverse effects from one of the COVID-19 vaccines purchased under the contracts can claim damages against the manufacturer of the vaccine[4].

[1] The Commission has pro-actively published redacted versions of the contracts concluded with the vaccine producers on its website.

[2] https://www.ema.europa.eu/en/human-regulatory-overview/pharmacovigilance-overview.

[3] This was intended as a risk sharing principle in the vaccine strategy.

[4] If the claim is successful, the Member State that administered the vaccine can, under certain conditions, be responsible for compensating the injured party and paying the vaccine manufacturer’s legal costs (indemnification).
Last updated: 23 June 2025
MIL OSI Europe News –
June 24, 2025
MIL-OSI Europe: Answer to a written question – Shortages of health workers in France and the EU – E-001540/2025(ASW)
Source: European Parliament

The Commission is currently implementing an Action Plan on labour and skills shortages of 20 March 2024[1]. The action plan sets out 87 actions or commitments that the EU, Member States and social partners will or should take to tackle these shortages.

It contains a call to Member States to develop policies to attract and retain nurses through improving working conditions and mentoring young professionals, with the support of the EU4Health Programme .

The collection of data for a survey on the health professionals’ mental health was carried out by the World Health Organisation (WHO) with EU4Health funding, and its results are planned to be published in October 2025. The WHO will then develop a set of proposed policy actions to protect the mental health of the health workforce, planned for publication before the end of 2025[2].

The Commission’s Expert Group on Health Systems Performance Assessment[3] is mapping various approaches to ensuring safe staffing levels in healthcare.

The Commission also helps Member States, including France, in seizing opportunities from the digitalisation of health systems. Among others, the European Health Data Space initiative[4] aims to establish a common framework for the use and exchange of electronic health data.

T hrough the European Semester, t he Commission provides country-specific policy advice to support health system reforms , including those related to the health workforce. Substantial EU funding[5] is available to support skills development programmes[6] and planning and forecasting tools[7].

I n the context of the Union of Skills[8] and its Skills Portability Initiative, the Commission will explore common rules for recognising the qualifications of third-country nationals, and thus facilitate the integration of non-EU workers into the EU labour markets, including in the healthcare sector.

The forthcoming Quality Jobs Roadmap will support progress on the various dimensions of job quality in the evolving world of work.
- [1] Commission Communication on Labour and skills shortages in the EU: an action plan, COM(2024) 131 final (https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:52024DC0131).
- [2] https://commission.europa.eu/strategy-and-policy/priorities-2019-2024/promoting-our-european-way-life/european-health-union/comprehensive-approach-mental-health_en.
- [3] https://health.ec.europa.eu/health-systems-performance-assessment_en.
- [4] https://health.ec.europa.eu/ehealth-digital-health-and-care/european-health-data-space-regulation-ehds_en.
- [5] https://health.ec.europa.eu/publications/2024-eu4health-work-programme_en.
- [6] Erasmus+ programme funded actions: AMR EDUCare https://www.amreducare.eu/, ‘BeWell’ https://bewell-project.eu/, DDS-MAP https://ddsmap.easpd.eu/, DigiCanTrain https://digicantrain.turkuamk.fi/contact-us/, e-Hospital4Future https://eh4future.eu/, EHMA https://hpass.healthworkforce.eu/EU4Health training https://health.ec.europa.eu/publications/2022-eu4health-work-programme_en; GESEA Educational Programme https://gesea.eu/ and TRANSiTION https://ehma.org/projects/transition/.
- [7] EU4Health Programme funded Joint Action Heroes: https://www.agenas.gov.it/ricerca-e-sviluppo/ricerca-internazionale/personale-sanitario-ri/heroes-health-workforce-to-meet-health-challenges.
- [8] https://op.europa.eu/en/publication-detail/-/publication/5c5c5399-fa8a-11ef-b7db-01aa75ed71a1.
MIL OSI Europe News –
June 24, 2025
MIL-OSI Europe: Answer to a written question – Systematic analysis of innovative cancer treatment options and patient survival – E-001448/2025(ASW)
Source: European Parliament
1. The Commission is fully committed to improving health outcomes for cancer patients through innovative therapies[1]. Under the EU4Health programme, the Joint Action on Personalised Cancer Medicine[2] will address the effectiveness of therapies. The European Cancer Information System[3] provides relevant data.

2. For primary use, the European Health Data Space will ensure citizens’ right to access and control their health data in an electronic format, and for secondary use, it will facilitate the access for research, innovation and policy making, contributing to optimise treatment and improve delivery of care.

3. The Horizon Europe[4] Cancer Mission[5] supports pragmatic clinical trials to test the effectiveness of therapies, including on surgery-centred technologies[6]. The Euratom Research and Training Programme[7] addresses research in the medical applications of ionising radiation, notably novel uses of radionuclides for the screening and treatment of cancer.

[1] For example, through Health Technology Assessment (HTA) Regulation (EU) 2021/2282, applicable since January 2025, which includes assessment of new cancer treatments, and the CAN.HEAL project developed common protocols to assess effectiveness of new cancer technologies.

[2] https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/eu4h-2024-pj-03-4.

[3] ECIS https://ecis.jrc.ec.europa.eu/; ECIS provides comparable statistical indicators and trends of cancer incidence, prevalence, mortality, and survival to monitor outcomes.

[4] https://research-and-innovation.ec.europa.eu/funding/funding-opportunities/funding-programmes-and-open-calls/horizon-europe_en.

[5] https://research-and-innovation.ec.europa.eu/funding/funding-opportunities/funding-programmes-and-open-calls/horizon-europe/eu-missions-horizon-europe/eu-mission-cancer_en.

[6] E.g. HORIZON-MISS-2025-02-CANCER-03, HORIZON-MISS-2025-02-CANCER-04; https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/how-to-participate/reference-documents;programCode=HORIZON?programmePeriod=2021-2027&frameworkProgramme=43108390.

[7] Council Regulation (Euratom) 2021/765 of 10 May 2021 establishing the Research and Training Programme of the European Atomic Energy Community for the period 2021-2025 complementing Horizon Europe — the framework Programme for Research and Innovation and repealing Regulation (Euratom) 2018/1563 (OJ 167I, 12.5.2021, p. 81, ELI: http://data.europa.eu/eli/reg/2021/765/oj).
Last updated: 23 June 2025
MIL OSI Europe News –
June 24, 2025
MIL-OSI USA: Florida Nonprofit Founder and Accountant Charged with Stealing Over $100M from Special Needs Victims

Source: US State of North Dakota

An indictment was unsealed today charging two Florida men in connection with a fraudulent scheme to steal over $100 million from a nonprofit organization that managed funds for people with special needs and disabilities.

“As alleged, for over 15 years, the defendants conspired to use the funds of special needs clients as a personal piggy bank, stealing $100 million dollars meant for the most vulnerable members of our society to enrich themselves,” said Matthew R. Galeotti, Head of the Justice Department’s Criminal Division. “Today’s charges reflect the Criminal Division’s ongoing commitment to prosecuting sophisticated fraudsters who abuse the trust of their victims. Thanks to the relentless efforts of our multiagency partners, we will continue to aggressively pursue accountability for perpetrators who exploit Americans out of greed.”

“Protecting the most vulnerable members of our society is a priority of the U. S. Attorney’s Office,” said U.S. Attorney Gregory W. Kehoe for the Middle District of Florida. “The fraud alleged in this nationwide scheme is unfathomable. Due to the diligence and interagency collaboration by our dedicated law enforcement partners, these crimes will be prosecuted to the fullest extent of the law.”

“The subjects charged are accused of creating a slush fund to divert millions of dollars away from a nonprofit organization helping people with special needs,” said Assistant Director Jose A. Perez of the FBI Criminal Investigative Division. “Not only were the organization’s resources drained, but the accused subjects betrayed the trust of the community and ultimately bankrupted a lifeline for vulnerable families. The FBI will not tolerate the exploitation of charitable missions for personal enrichment.”

“The scale and audacity of the alleged fraud in this case are deeply troubling,” said Criminal Investigation Chief Guy Ficco of the IRS. “Stealing funds intended to protect and support people with special needs is as cruel as it is criminal. IRS-CI special agents are dedicated to uncovering complex financial schemes, especially those that prey on the most vulnerable in our society.”

“The defendant disrupted access to critical services for individuals with disabilities and defrauded federal health care programs with the sole purpose of financing a life of extravagance,” said Deputy Inspector General for Investigations Christian J. Schrank of the U. S. Department of Health and Human Services Office of Inspector General (HHS-OIG). “HHS-OIG, in collaboration with our law enforcement partners, will continue to hold those who’s illicit actions seek to assail enrollees and the nation’s federal health care programs fully accountable.”

According to court documents, Leo John Govoni, 67, of Clearwater, Florida, co-founded the Center for Special Needs Trust Administration (CSNT) in or around 2000 and John Leo Witeck, 60, of Tampa, Florida, worked at CSNT as an accountant. CSNT allegedly was a nonprofit that managed money for people with disabilities and other special needs, including those who received court awards, settlements, and other payments. CSNT grew to be one of the largest administrators of special needs trusts in the country, with beneficiaries located in almost every state. As of February 2024, the indictment alleges, CSNT managed over 2,100 special needs trusts containing approximately $200 million.

As alleged in the indictment, from June 2009 through May 2025, Govoni, Witeck, and their co-conspirators solicited, stole, and misappropriated CSNT client-beneficiary funds — which they treated as a slush fund to enrich themselves and others — and concealed their illegal activities through complex financial transactions and deceit, including sending fraudulent account statements with false balances to disabled victims. Govoni allegedly used stolen money to purchase real estate, travel via private jet, fund a brewery, make deposits into his personal bank accounts, and pay personal debts. In 2024, CSNT filed for bankruptcy and disclosed that more than $100 million in client-beneficiary funds were missing from its trust accounts. Govoni is alleged to have made false declarations to the bankruptcy court related to the CSNT bankruptcy proceedings.

Separately, Govoni is also alleged to have committed bank fraud related to a $3 million mortgage refinance loan and to have laundered $205,054 of the proceeds to pay off a home equity line of credit on his residence.

Govoni and Witeck were both charged with conspiracy to commit wire and mail fraud, wire fraud, mail fraud, and money laundering conspiracy. Govoni was additionally charged with bank fraud, illegal monetary transactions, and false bankruptcy declarations.

If convicted, both defendants face a maximum penalty of 20 years in prison on the wire fraud, mail fraud, conspiracy to commit wire and mail fraud, and money laundering conspiracy charges. If convicted, Govoni faces a maximum penalty of 30 years in prison on the bank fraud charge, 10 years in prison on the illegal monetary transactions charge, and five years in prison on the false bankruptcy declaration charge.

The FBI, IRS-CI, HHS-OIG, and SSA-OIG are investigating the case.

Trial Attorney Lyndie Freeman of the Criminal Division’s Fraud Section and Assistant U. S. Attorneys Jennifer Peresie and Michael Gordon for the Middle District of Florida are handling the prosecution.

An indictment is merely an allegation. All defendants are presumed innocent until proven guilty beyond a reasonable doubt in a court of law.

MIL OSI USA News –

June 24, 2025
MIL-OSI Security: Chesterfield Doctor Sentenced to Five Years in Prison for Healthcare Fraud

Source: US FBI

ST. LOUIS – U.S. District Judge Henry E. Autrey on Friday sentenced a doctor who committed healthcare fraud to five years in prison and ordered him to repay $2.87 million.

Dr. Stanley L. Librach, now 64, of Chesterfield, pleaded guilty in August in U.S. District Court in St. Louis to one count of conspiracy, one count of illegally prescribing controlled substances, one count of paying illegal kickbacks for referrals and one count of health care fraud. He admitted participating in healthcare fraud schemes involving both kickbacks and the illegal prescribing of controlled substances.

In one scheme, Dr. Librach, Dr. Asim Muhammad Ali, and chiropractor Jerry Dale Leech agreed to send urine samples for testing to Central Diagnostic Laboratory (CDL) in exchange for illegal kickbacks that went to business entities owned by Leech and Denis J. Mikhlin. CDL then sought reimbursement from Medicare and Medicaid for the testing. Dr. Librach also sent urine samples directly from his own separate private practice clinic to CDL. In exchange, Dr. Ali paid the wages of Dr. Librach’s employees.

In another scheme, Dr. Librach, Dr. Ali and Leech wrote prescriptions for the powerful pain medication oxycodone and other controlled substances when there was no legitimate medical purpose and while acting outside the usual course of professional conduct. Drs. Librach and Ali had not examined the patients at the pain clinics with which they were associated. They did not determine that the patients whose names appeared on prescriptions had a medical need for the controlled substances. Instead, they spent several hours one day a week pre-signing prescriptions that would be used for patients at upcoming visits. The doctors did not examine or evaluate the patients and rarely looked at patient charts before signing prescriptions. The doctors signed prescriptions for patients whose test results indicated that they were selling or otherwise diverting the controlled substances and did not address that obvious drug diversion. The conspirators knew that pharmacies would seek reimbursement for the medications from Medicare and Medicaid.

“This provider was involved in multiple elaborate healthcare fraud schemes that involved accepting kickbacks and illegally prescribing dangerous and addictive opioids for financial gain,” said Linda T. Hanley, Special Agent in Charge with the U.S. Department of Health and Human Services, Office of the Inspector General (HHS-OIG). “HHS-OIG remains committed to working closely with our law enforcement partners to protect patients and protect the integrity of federal healthcare programs.”

Special Agent in Charge Michael A. Davis heads the Drug Enforcement Administration division that leads DEA investigations in Kansas and Missouri. “Because opioids are highly addictive, doctors have a duty to ensure they are prescribing controlled medications according to law to protect their patients’ health and safety,” said Davis.

Eleven defendants were indicted in 2020, including three doctors, their staff and purported patients. A twelfth was added in 2022. All have pleaded guilty.

Dr. Ali, 54, of Creve Coeur, pleaded guilty in May of 2024 to charges similar to the ones to which Dr. Librach pleaded. He is scheduled to be sentenced in August. Leech, 52, of Creve Coeur, pleaded guilty in 2021 to one count of conspiracy, one count of obtaining a controlled substance by fraud, one count of paying illegal kickbacks for referrals and one count of health care fraud. He is scheduled to be sentenced in September. Mikhlin, 46, of Chesterfield, was sentenced in 2021 to nine years in prison and ordered to repay $181,265.

The HHS-OIG, the DEA, the Missouri Attorney General’s Medicaid Fraud Control Unit, the Federal Bureau of Investigation, the Defense Criminal Investigative Service investigated the case. Assistant U.S. Attorneys Amy Sestric, Derek Wiseman and Jonathan Clow are prosecuting the case.

MIL Security OSI –

June 24, 2025
MIL-OSI Security: Florida Nonprofit Founder and Accountant Charged with Stealing Over $100M from Special Needs Victims

Source: United States Attorneys General

An indictment was unsealed today charging two Florida men in connection with a fraudulent scheme to steal over $100 million from a nonprofit organization that managed funds for people with special needs and disabilities.

“As alleged, for over 15 years, the defendants conspired to use the funds of special needs clients as a personal piggy bank, stealing $100 million dollars meant for the most vulnerable members of our society to enrich themselves,” said Matthew R. Galeotti, Head of the Justice Department’s Criminal Division. “Today’s charges reflect the Criminal Division’s ongoing commitment to prosecuting sophisticated fraudsters who abuse the trust of their victims. Thanks to the relentless efforts of our multiagency partners, we will continue to aggressively pursue accountability for perpetrators who exploit Americans out of greed.”

“Protecting the most vulnerable members of our society is a priority of the U. S. Attorney’s Office,” said U.S. Attorney Gregory W. Kehoe for the Middle District of Florida. “The fraud alleged in this nationwide scheme is unfathomable. Due to the diligence and interagency collaboration by our dedicated law enforcement partners, these crimes will be prosecuted to the fullest extent of the law.”

“The subjects charged are accused of creating a slush fund to divert millions of dollars away from a nonprofit organization helping people with special needs,” said Assistant Director Jose A. Perez of the FBI Criminal Investigative Division. “Not only were the organization’s resources drained, but the accused subjects betrayed the trust of the community and ultimately bankrupted a lifeline for vulnerable families. The FBI will not tolerate the exploitation of charitable missions for personal enrichment.”

“The scale and audacity of the alleged fraud in this case are deeply troubling,” said Criminal Investigation Chief Guy Ficco of the IRS. “Stealing funds intended to protect and support people with special needs is as cruel as it is criminal. IRS-CI special agents are dedicated to uncovering complex financial schemes, especially those that prey on the most vulnerable in our society.”

“The defendant disrupted access to critical services for individuals with disabilities and defrauded federal health care programs with the sole purpose of financing a life of extravagance,” said Deputy Inspector General for Investigations Christian J. Schrank of the U. S. Department of Health and Human Services Office of Inspector General (HHS-OIG). “HHS-OIG, in collaboration with our law enforcement partners, will continue to hold those who’s illicit actions seek to assail enrollees and the nation’s federal health care programs fully accountable.”

According to court documents, Leo John Govoni, 67, of Clearwater, Florida, co-founded the Center for Special Needs Trust Administration (CSNT) in or around 2000 and John Leo Witeck, 60, of Tampa, Florida, worked at CSNT as an accountant. CSNT allegedly was a nonprofit that managed money for people with disabilities and other special needs, including those who received court awards, settlements, and other payments. CSNT grew to be one of the largest administrators of special needs trusts in the country, with beneficiaries located in almost every state. As of February 2024, the indictment alleges, CSNT managed over 2,100 special needs trusts containing approximately $200 million.

As alleged in the indictment, from June 2009 through May 2025, Govoni, Witeck, and their co-conspirators solicited, stole, and misappropriated CSNT client-beneficiary funds — which they treated as a slush fund to enrich themselves and others — and concealed their illegal activities through complex financial transactions and deceit, including sending fraudulent account statements with false balances to disabled victims. Govoni allegedly used stolen money to purchase real estate, travel via private jet, fund a brewery, make deposits into his personal bank accounts, and pay personal debts. In 2024, CSNT filed for bankruptcy and disclosed that more than $100 million in client-beneficiary funds were missing from its trust accounts. Govoni is alleged to have made false declarations to the bankruptcy court related to the CSNT bankruptcy proceedings.

Separately, Govoni is also alleged to have committed bank fraud related to a $3 million mortgage refinance loan and to have laundered $205,054 of the proceeds to pay off a home equity line of credit on his residence.

Govoni and Witeck were both charged with conspiracy to commit wire and mail fraud, wire fraud, mail fraud, and money laundering conspiracy. Govoni was additionally charged with bank fraud, illegal monetary transactions, and false bankruptcy declarations.

If convicted, both defendants face a maximum penalty of 20 years in prison on the wire fraud, mail fraud, conspiracy to commit wire and mail fraud, and money laundering conspiracy charges. If convicted, Govoni faces a maximum penalty of 30 years in prison on the bank fraud charge, 10 years in prison on the illegal monetary transactions charge, and five years in prison on the false bankruptcy declaration charge.

The FBI, IRS-CI, HHS-OIG, and SSA-OIG are investigating the case.

Trial Attorney Lyndie Freeman of the Criminal Division’s Fraud Section and Assistant U. S. Attorneys Jennifer Peresie and Michael Gordon for the Middle District of Florida are handling the prosecution.

An indictment is merely an allegation. All defendants are presumed innocent until proven guilty beyond a reasonable doubt in a court of law.

MIL Security OSI –

June 24, 2025
MIL-OSI USA: Upcoming Presentations by Staff of CBO’s Health Analysis Division

Source: US Congressional Budget Office

This summer, several of my colleagues in the Congressional Budget Office’s Health Analysis Division will present their work in three sessions at the 14th Annual Conference of the American Society of Health Economists (ASHEcon) in Nashville, Tennessee. The presentations are part of the agency’s ongoing efforts to engage with the broader research community. Those efforts include calls for research, such as the agency’s recent blog post on nutritional standards in the Supplemental Nutrition Assistance Program; public posting of code; and updates on ongoing work. By engaging with researchers outside the agency, CBO improves the quality of its analysis and makes its methods and findings more transparent and available. We look forward to discussion and feedback on the following topics of this summer’s presentations:

Spotlight Session: Putting Research to Work: How CBO Uses Research to Inform Policymakers

Presenters
Noelia Duchovny (CBO), Sean Lyons (CBO), Jared Maeda (CBO), J. Michael McWilliams (Harvard Medical School), Mark Shepard (Harvard University), and Bryan Tysinger (USC Schaeffer Center)

Moderator
Tamara Hayford (CBO)

Session
Spotlight Session: Putting Research to Work: How CBO Uses Research to Inform Policymakers

Description
CBO uses published research and discussions with experts to inform the agency’s analytical work, including estimates of the budgetary effects of proposed legislation. In addition, CBO actively engages with the research community to develop the agency’s evidence base and analytical methods. For example, CBO has published four blog posts in the past two years calling for new research on topics in the health space ranging from how health care providers respond to cost shocks to take-up rates and costs of treatment for complications from hepatitis C. Because CBO is often tasked with projecting the impact of new programs or policies on the federal budget, descriptive data and research on the impact of policy, health, and pricing shocks on health care service use and spending are particularly valuable to the agency. In this session, CBO’s Health Analysis Division highlights three examples of research that have been particularly helpful. The session will include short presentations by study authors, discussions of how the work was used and what made it helpful by CBO analysts, and a Q&A at the end for session attendees to learn about CBO’s work and what makes research particularly useful and informative.

Tracking the Incidence of Medicare Advantage Payments

Presenter
Eric Schulman

Session
Poster Reception

Authors
Jared Maeda (CBO) and Eric Schulman (CBO)

Abstract
This paper investigates how nominal payments to Medicare Advantage (MA) plans have changed over time and how those changes have shaped economic outcomes for plans and beneficiaries. The question is policy-relevant because of differences in the relationships between benchmarks, enrollment, and benefit generosity under the Benefits Improvement and Protection Act (BIPA) and the Affordable Care Act (ACA), which potentially contributed to inaccurate forecasts of the ACA’s impact. A potential reason for the difference between projected and actual outcomes is that regulatory rulemaking shaped actual payment amounts in unexpected ways. For example, although the ACA lowered MA benchmarks, total payments increased because of simultaneous growth in risk adjustment payments, complicating efforts to measure the economic incidence of the ACA (that is, which parties ultimately benefited from or bore the burden of payment changes). Our project examines the extent to which local-level, rule-based changes in payments affected who benefited or bore the burden of the ACA payment changes, compared with changes to plans and beneficiary behavior.

Initial descriptive statistics suggest that BIPA’s payment floors functioned as a progressive subsidy that primarily benefited rural, low-spending counties, whereas the ACA payment cuts were proportional to spending and concentrated in high-spending urban areas. That geographic pattern suggests that local market conditions—such as insurer competition, beneficiary health profiles, and physician practices—may significantly shape the incidence of payment reforms. Our descriptive findings so far highlight the need to further investigate how local market characteristics interact with the Centers for Medicare & Medicaid Services’s (CMS’s) rulemaking around plan finances to determine which parties benefit from or bear the burden of payment changes. As a next step, we intend to decompose the variation in plan payments, premiums, and benefits into components explained by observable factors (such as benchmarks, risk scores, quality bonuses, and rule-based elements in the CMS bidding tool) and unobservable factors (such as behavioral responses) to better understand the economic incidence of the ACA.

Substitution Between Medicare Advantage and Medigap

Presenter
Daria Pelech

Session
Enrollment Decision-Making in Medicare Advantage

Authors
Daria Pelech (CBO) and Margaret Kallus (UC Berkeley Economics)

Abstract
Though Medicare fee-for-service (FFS) covers many benefits, the program’s cost-sharing structure can expose beneficiaries to substantial financial risk. To protect against that risk, most beneficiaries obtain additional coverage. Historically, many beneficiaries have purchased supplemental Medigap policies—private insurance plans that “wrap around” Medicare FFS and cover Medicare FFS deductibles, copayments, and coinsurances. Increasingly, however, Medicare beneficiaries have enrolled in Medicare Advantage (MA) plans, in which a private insurer covers enrollees’ Medicare benefits and often restructures their cost-sharing to reduce enrollees’ financial risk. As of 2024, just over half of all Medicare beneficiaries were enrolled in MA, up from less than a third a decade earlier. Because Medigap and MA fill some of the same financial needs for many beneficiaries—defraying the cost of the traditional Medicare benefit—the premiums and availability of Medigap policies likely influence beneficiaries’ choices between Medicare FFS and MA. In the past decade, Medigap premiums have grown with inflation while MA premiums have largely stayed flat. The diverging affordability between those options might explain some of the increase in MA enrollment over the past 20 years.

This paper combines detailed data on Medigap premiums and Medicare enrollment to estimate the effect of Medigap premiums on MA enrollment. Specifically, we estimate how variation in Medigap premiums affects the probability that beneficiaries who are newly enrolling in Medicare choose MA. We also estimate the probability that MA enrollees leave their plans following a health shock or an increase in MA premiums. Using brokerage data on Medigap premiums, we estimate the average and minimum premiums each individual might face on the basis of their age, gender, zip code, and eligibility for an open-enrollment period. We combine that with a 10-year panel of individual Medicare enrollment data identifying beneficiaries who are new to Medicare or who disenroll from their MA plans. For enrollees who are new to Medicare, we estimate their probability of enrolling in MA on the basis of Medigap premiums and characteristics of the MA market in their area. For individuals who are enrolled in MA, we match Medicare enrollment data to external data from the Centers for Medicare & Medicaid Services using MA plan identifiers to identify which plans have experienced changes in premiums or benefits (which might induce a beneficiary to shop for a new plan) and which plans have been canceled (which requires a beneficiary to select a new plan). We also use individual-level beneficiary risk scores to identify beneficiaries who experience large health shocks, to compare their probability of leaving MA with that of other beneficiaries.

The results of this study will help us better understand Medigap’s role in the increase in MA enrollment, which in turn will help improve future projections of MA enrollment growth. The results will also inform estimates of policies that might change Medigap or MA availability—such as guaranteed open-enrollment periods for those who leave their MA plans or changes in payments to MA plans.

Chapin White is CBO’s Director of Health Analysis.

MIL OSI USA News –

June 24, 2025
MIL-OSI Security: Three Arizona Business Associates Now Charged with Operating Fraudulent Medical Clinics and Prescribing Unapproved Drugs to Treat Cancer
Source: US FBI

PHILADELPHIA – United States Attorney David Metcalf announced that a superseding indictment (“indictment”) was filed earlier this month, charging Mary Blakley (aka “Marye Blakley,” “Mary Blakely,” “Mary Blakeley,” “Mary Davis,” “Mary Venable,” “Mary Cammer,” “Rosemary Cammer,” “Rosemary Davis,” “Yvonne Davis,” and “Mary Blaksley”) and Fred Blakley (aka “Fred Blakely” and “Floyd Blakely”) with conspiracy to commit mail and wire fraud, mail fraud, wire fraud, and conspiracy to violate the Food, Drug, and Cosmetic Act and defraud the Food and Drug Administration (“FDA”). In addition to the Blakleys, both charged previously, the superseding indictment also charged Janmarie Lanzo with conspiracy to violate the Food, Drug, and Cosmetic Act and defraud the FDA. All three defendants are residents of Lake Havasu City, Arizona.

The indictment alleges that the Mary Blakley, who described herself as “Doctor Mary,” and Fred Blakley were the principals of a medical clinic business that charged clients throughout the United States approximately $300 for conducting what the defendants described as “full body scans” by use of an ultrasound machine. Janmarie Lanzo was a business associate of Mary and Fred Blakley, who worked in the clinics and sold products to clients that were recommended by Mary Blakley as a result of the scans.

The defendants falsely claimed that, through the deployment of a “smart chip technology” supposedly invented by defendant Mary Blakley and purportedly added to the ultrasound machines, their “full body scans” could diagnose a wide variety of human diseases and medical conditions, including cancers. Based on the results of these “full body scans,” the defendants falsely and fraudulently prescribed to their human clients various supplements, creams, and veterinary products.

The indictment alleges that the defendants promoted and sold Aetheion, a product marketed as a cosmetic cream, to treat cancer, gastric hernias, and various other conditions. The defendants also promoted and sold fenbendazole, a veterinary antiparasitic, to treat cancer in humans.

The indictment alleges that to conceal their scheme, the defendants:
- Falsely claimed they were only doing research, when they were actually performing services and distributing and selling products;
- Falsely claimed that the products and services they were performing, distributing, and selling were of a type for which regulatory requirements were less onerous or nonexistent;
- Used coded language and coached others to take deceptive measures;
- Disguised the nature of the clinics as a religious organization, health club, and private membership organization; and
- Required clients to execute confidentiality agreements.
If convicted, Mary Blakley and Fred Blakley face a maximum possible sentence of 165 years in prison. If convicted, Janmarie Lanzo faces a maximum possible sentence of five years in prison.

The case was investigated by the FBI and the Office of Criminal Investigations of the Food and Drug Administration, and is being prosecuted by Assistant United States Attorneys Ruth Mandelbaum and Paul G. Shapiro.

The charges and allegations contained in the indictment are merely accusations. Every defendant is presumed to be innocent unless and until proven guilty in court.

MIL Security OSI –
June 24, 2025
MIL-OSI Analysis: How to protect your favourite urban trees from increasing danger

Source: The Conversation – UK – By Lucy Grace, PhD Candidate, Climate Change and Literature, Nottingham Trent University

Whether your favourite tree is in a private garden, on wasteland, in a school playground or on the street, your emotional response may be admiration, relaxation, rejuvenation or awareness of the seasons passing. But so many special trees are experiencing a combination of threats.

According to a new report from environmental charity the Tree Council and government-funded agency Forest Research, introduced pests and diseases, pollution, extreme weather and infrastructure development are all on the increase, which could be a disaster for the UK’s trees. These affect trees’ condition, resilience and capacity to mitigate the climate and nature crises.

Not only do trees play ecological roles in nature, such as shelter for wildlife and protection from floods, many people have long-standing connections to trees. A report from the Tree Council highlights the role of trees as an important part of the “fabric of human cultures and societies”.

This demonstrates a move away from appreciating only the ecological benefits provided by urban trees and towards the social and cultural importance they hold for local populations.

Get your news from actual experts, straight to your inbox. Sign up to our daily newsletter to receive all The Conversation UK’s latest coverage of news and research, from politics and business to the arts and sciences.

The ecological and biodiversity values of trees are well-documented. Trees offer homes and food for birds, insects and wildlife. They prevent rainwater reaching the ground by as much as 45%. When combined with grass, surface water flooding is reduced by 99% compared with tarmac. Urban trees reduce air pollution, quieten noise and keep cities shaded and cool.

Thousands of people cast votes for their favourite trees in the UK and Europe. In a recent study, over half of 1,800 adults surveyed said they had a favourite tree and 74% felt that urban development is the greatest threat to our trees.

That’s not the only threat, though. Single species planting of street trees, for example, leaves the trees vulnerable to diseases (such as Dutch elm or ash dieback). Rising temperatures and water scarcity leaves trees competing for resources.

But what does that mean for our urban trees? Approximately 30% of tree cover in England exists outside forest and woodland. Such trees form an essential habitat in urban areas where 83% of the UK’s population live, yet more than ever before our urban trees are facing threats from a deadly combination of environmental change and human development. In Wales, for example, 7,000 mature trees in towns and cities were lost between 2006 and 2013.

To try to address this growing crisis, woodland charity Forest Research have released a new, national free to use “trees outside woodland” map. This refers to any trees found in settings such as parks, open countryside and farmland, gardens and estates, or beside roads and paths.

These can be on a street corner, beside a railway track or in a market square and includes very old trees like those listed on the ancient tree inventory plus otherwise unremarkable trees growing in unusual settings, such as the vandalised 200-year-old Sycamore Gap tree.

Why we love trees

England is dawdling behind many other countries when it comes to protecting important trees. Forest Research found that trees outside woodland share many of the social and cultural values associated with trees in woodlands, however people make specific relationships with these urban trees and they are more likely to be considered unique and irreplaceable.

Trees in urban areas have huge social benefits too.
Karo Martu/Shutterstock

They can be recognised for their grace and beauty or for their associations with customs, beliefs and rituals. They can be a place to rest and play and symbols of community belonging. They can give a sense of continuity, connecting people’s lifespans with reflections about the natural world and everything beyond.

Many countries give clear titles to their important trees. In Poland, they are called natural monuments, in Germany they are living monuments. Spain, Belgium, Greece, Mexico and Finland use the term “monumental trees”. In New Zealand, special urban trees are referred to as national living landmarks. Currently England falls behind in designating trees for protection based on their historical or aesthetic importance.

Trees for everyone

A common feature across many countries is the opportunity for anyone, including members of the public, to recommend a tree for protection. Tree equity is the idea that everyone should have access to the benefits of trees. It includes prioritising and deploying resources in the areas where people have least access to them.

Tree inequity exists in most UK towns and cities. On average, the most economically and socially deprived and most ethnically diverse neighbourhoods have half the tree canopy cover compared to the least deprived and least diverse.

Canopy cover ranges from 1–2% in parts of north-east England to 36% in Hampstead, north London. Even within London there are wide variations.

So ensure your favourite tree can be appreciated and celebrated by your community as a living monument, make sure it is on the Trees Outside Woodland map. And check if it needs a drink.

Don’t have time to read about climate change as much as you’d like?

Get a weekly roundup in your inbox instead. Every Wednesday, The Conversation’s environment editor writes Imagine, a short email that goes a little deeper into just one climate issue. Join the 45,000+ readers who’ve subscribed so far.

Lucy Grace receives funding from AHRC for her PhD through the Midlands4Cities Doctoral Training Partnership.

– ref. How to protect your favourite urban trees from increasing danger – https://theconversation.com/how-to-protect-your-favourite-urban-trees-from-increasing-danger-258227

MIL OSI Analysis –

June 24, 2025
MIL-OSI Analysis: How to protect your favourite urban trees from increasing danger

Source: The Conversation – UK – By Lucy Grace, PhD Candidate, Climate Change and Literature, Nottingham Trent University

Whether your favourite tree is in a private garden, on wasteland, in a school playground or on the street, your emotional response may be admiration, relaxation, rejuvenation or awareness of the seasons passing. But so many special trees are experiencing a combination of threats.

According to a new report from environmental charity the Tree Council and government-funded agency Forest Research, introduced pests and diseases, pollution, extreme weather and infrastructure development are all on the increase, which could be a disaster for the UK’s trees. These affect trees’ condition, resilience and capacity to mitigate the climate and nature crises.

Not only do trees play ecological roles in nature, such as shelter for wildlife and protection from floods, many people have long-standing connections to trees. A report from the Tree Council highlights the role of trees as an important part of the “fabric of human cultures and societies”.

This demonstrates a move away from appreciating only the ecological benefits provided by urban trees and towards the social and cultural importance they hold for local populations.

Get your news from actual experts, straight to your inbox. Sign up to our daily newsletter to receive all The Conversation UK’s latest coverage of news and research, from politics and business to the arts and sciences.

The ecological and biodiversity values of trees are well-documented. Trees offer homes and food for birds, insects and wildlife. They prevent rainwater reaching the ground by as much as 45%. When combined with grass, surface water flooding is reduced by 99% compared with tarmac. Urban trees reduce air pollution, quieten noise and keep cities shaded and cool.

Thousands of people cast votes for their favourite trees in the UK and Europe. In a recent study, over half of 1,800 adults surveyed said they had a favourite tree and 74% felt that urban development is the greatest threat to our trees.

That’s not the only threat, though. Single species planting of street trees, for example, leaves the trees vulnerable to diseases (such as Dutch elm or ash dieback). Rising temperatures and water scarcity leaves trees competing for resources.

But what does that mean for our urban trees? Approximately 30% of tree cover in England exists outside forest and woodland. Such trees form an essential habitat in urban areas where 83% of the UK’s population live, yet more than ever before our urban trees are facing threats from a deadly combination of environmental change and human development. In Wales, for example, 7,000 mature trees in towns and cities were lost between 2006 and 2013.

To try to address this growing crisis, woodland charity Forest Research have released a new, national free to use “trees outside woodland” map. This refers to any trees found in settings such as parks, open countryside and farmland, gardens and estates, or beside roads and paths.

These can be on a street corner, beside a railway track or in a market square and includes very old trees like those listed on the ancient tree inventory plus otherwise unremarkable trees growing in unusual settings, such as the vandalised 200-year-old Sycamore Gap tree.

Why we love trees

England is dawdling behind many other countries when it comes to protecting important trees. Forest Research found that trees outside woodland share many of the social and cultural values associated with trees in woodlands, however people make specific relationships with these urban trees and they are more likely to be considered unique and irreplaceable.

Trees in urban areas have huge social benefits too.
Karo Martu/Shutterstock

They can be recognised for their grace and beauty or for their associations with customs, beliefs and rituals. They can be a place to rest and play and symbols of community belonging. They can give a sense of continuity, connecting people’s lifespans with reflections about the natural world and everything beyond.

Many countries give clear titles to their important trees. In Poland, they are called natural monuments, in Germany they are living monuments. Spain, Belgium, Greece, Mexico and Finland use the term “monumental trees”. In New Zealand, special urban trees are referred to as national living landmarks. Currently England falls behind in designating trees for protection based on their historical or aesthetic importance.

Trees for everyone

A common feature across many countries is the opportunity for anyone, including members of the public, to recommend a tree for protection. Tree equity is the idea that everyone should have access to the benefits of trees. It includes prioritising and deploying resources in the areas where people have least access to them.

Tree inequity exists in most UK towns and cities. On average, the most economically and socially deprived and most ethnically diverse neighbourhoods have half the tree canopy cover compared to the least deprived and least diverse.

Canopy cover ranges from 1–2% in parts of north-east England to 36% in Hampstead, north London. Even within London there are wide variations.

So ensure your favourite tree can be appreciated and celebrated by your community as a living monument, make sure it is on the Trees Outside Woodland map. And check if it needs a drink.

Don’t have time to read about climate change as much as you’d like?

Get a weekly roundup in your inbox instead. Every Wednesday, The Conversation’s environment editor writes Imagine, a short email that goes a little deeper into just one climate issue. Join the 45,000+ readers who’ve subscribed so far.

Lucy Grace receives funding from AHRC for her PhD through the Midlands4Cities Doctoral Training Partnership.

– ref. How to protect your favourite urban trees from increasing danger – https://theconversation.com/how-to-protect-your-favourite-urban-trees-from-increasing-danger-258227

MIL OSI Analysis –

June 24, 2025
MIL-OSI Global: Mounjaro becomes available on the NHS: what to know and what to do if you’re not eligible

Source: The Conversation – UK – By Dan Baumgardt, Senior Lecturer, School of Physiology, Pharmacology and Neuroscience, University of Bristol

bigshot01/Shutterstock

Obesity remains one of the most pressing, and preventable, health challenges of our time. The UK is one of a number of countries undoubtedly struggling with it.

It affects nearly every organ system in the body, contributing to cardiovascular conditions like coronary heart disease; musculoskeletal issues such as osteoarthritis and gout; and even the development of certain cancers, including of the breast, uterus and colon. Its impact on mental health is also significant.

A few years ago, injectable weight-loss drugs entered clinical use and quickly captured public attention for their ability to promote rapid fat loss. Ozempic is available on the NHS, but only for managing type 2 diabetes. Wegovy is authorised for weight loss and cardiovascular risk reduction and is also available on the NHS, though access is currently limited to specialist weight management services.

Now, a new option has emerged: Mounjaro, which is approved for both type 2 diabetes and weight loss. This dual-purpose drug is now available on the NHS, offering another potential tool in the fight against obesity.

Demand is expected to be high. However, access will be limited at first, with strict eligibility criteria for NHS prescriptions.

Get your news from actual experts, straight to your inbox. Sign up to our daily newsletter to receive all The Conversation UK’s latest coverage of news and research, from politics and business to the arts and sciences.

What is Mounjaro?

Mounjaro (tirzepatide) is a once weekly injectable medication designed to help control blood-sugar levels. It works by boosting the secretion and effects of insulin, improving glycaemic control in people with Type 2 diabetes. It also slows gastric emptying — the process by which food leaves the stomach — and enhances feelings of fullness by acting on the brain. This combined effect reduces appetite and helps support weight loss.

Compared to similar medications like Ozempic and Wegovy (both brand names for semaglutide), clinical trials found Mounjaro more effective, with some participants losing up to 20% of their body weight over a 72-week period.

Read more:
The best exercises to do while taking weight loss drugs

Who is eligible for Mounjaro on the NHS?

The NHS has introduced specific criteria to prioritise patients most in need.

First, patients need a BMI of 40 or more (classified as morbid obesity). People from certain ethnic backgrounds, such as South Asian communities, may be eligible at a lower BMI due to higher clinical risk of health conditions.

Second, at least four obesity-related health conditions must be diagnosed, including type 2 diabetes, hypertension (high blood pressure), dyslipidaemia (abnormal cholesterol or triglyceride levels), cardiovascular disease and obstructive sleep apnoea. (Some of these conditions often occur together; for example, high blood pressure and cholesterol.)

Patients are encouraged to check their BMI and confirm their diagnoses before contacting a GP. This helps ensure appointments are used effectively and discussions remain focused.

While the current criteria are strict, there is optimism that eligibility will broaden in the coming years to include people with lower BMIs and fewer co-morbidities.

Not eligible? Don’t despair

The NHS continues to offer a comprehensive weight-loss programme, tiered according to BMI and previous attempts at weight loss. Don’t underestimate the value of group-based programmes or community referrals – when a healthcare professional refers a patient to a community-based health service for further care or support – many of which can be accessed via your GP.

These services, such as the NHS digital weight management programme, support both individuals and families and can be highly effective for sustainable fat loss.

GPs may also refer patients to online courses and structured exercise programmes. Lifestyle interventions, including increased physical activity and healthier eating, remain cornerstones of obesity treatment and are critical for long-term success, even when medications are used.

Read more:
From diet to drugs: what really works for long-term weight loss

Higher tier interventions may be considered if lifestyle changes fail or if the patient has significant co-morbidities. This is where medications like Mounjaro, or private prescriptions, may become relevant – albeit that the cost of the latter may be a limiting factor for some.

Other treatments include Orlistat, a medication that reduces fat absorption in the gut. This can be effective for some but often causes unpleasant side effects, such as oily stools and gastrointestinal upset

Gastric banding or surgery may also result in significant, sustained weight loss, but they come with risks, can lead to surgical complications, and recovery can be demanding

It’s also important to recognise that drugs like Mounjaro aren’t suitable for everyone. They can cause side effects significant enough for people to stop using them, and in some cases, they may not work at all.

In this new era of faster, medication-assisted weight loss, we must remember that long-term change is about more than quick fixes. Sustainable success comes from consistent effort, willingness to change and methods that are both practical and lasting.

Medications can help, sometimes dramatically, but they’re not the only answer. A return to basics, with tailored support and realistic goals, remains as relevant as ever.

So whether you qualify for Mounjaro, are trying lifestyle changes, or are exploring other options, remember this: the journey to better health is personal, gradual and worth it.

Dan Baumgardt does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

– ref. Mounjaro becomes available on the NHS: what to know and what to do if you’re not eligible – https://theconversation.com/mounjaro-becomes-available-on-the-nhs-what-to-know-and-what-to-do-if-youre-not-eligible-259582

MIL OSI – Global Reports –

June 24, 2025
MIL-OSI USA: New Cantwell Fact Sheet: Republican Bill Threatens to Upend WA’s Reproductive Health System & Increase Costs as Three-Year Dobbs Decision Anniversary Approaches

US Senate News:

Source: United States Senator for Washington Maria Cantwell
06.23.25
New Cantwell Fact Sheet: Republican Bill Threatens to Upend WA’s Reproductive Health System & Increase Costs as Three-Year Dobbs Decision Anniversary Approaches
Health care professionals warn of labor & delivery department closures, higher rates of breast and cervical cancer due to missed screenings, & heightened trauma for sexual assault survivors; Republican bill would bar Planned Parenthood from receiving federal Medicaid funding, straining care options for all
WASHINGTON, D.C. – Today, one day before the third anniversary of the Dobbs v. Jackson Women’s Health Organization Supreme Court decision that overturned Roe v. Wade, U.S. Senator Maria Cantwell (D-WA), ranking member of the Senate Committee on Commerce, Science, and Transportation and senior member of the Senate Finance Committee, warned of dire consequences for reproductive health care in Washington state if the Republican reconciliation bill is passed.
“In the State of Washington, Planned Parenthood serves about 100,000 patients annually,” said Sen. Cantwell at a May 14 press conference with Planned Parenthood president Alexis McGill Johnson. “About half of those patients rely on Medicaid. And it accounts for about half of the annual budget of Planned Parenthood [of Greater Washington and North Idaho]. These clinics and their patients count on that delivering care.”
Sen. Cantwell issued a new fact sheet with details about the proposed cuts, and exclusive new testimonials from patients, doctors, and other health care professionals about how the cuts would impact Washingtonians.

MIL OSI USA News –

June 24, 2025
MIL-OSI United Kingdom: Business leaders welcome the government’s modern Industrial Strategy
Source: United Kingdom – Executive Government & Departments

Press release

Business leaders welcome the government’s modern Industrial Strategy

Business leaders have welcomed the government’s modern Industrial Strategy – a 10-year plan to promote growth.
Business leaders from across the UK have welcomed the government’s modern Industrial Strategy. The Strategy is a 10-year plan to promote business investment and growth and make it quicker, easier and cheaper to do business in the UK.

The plan focuses on 8 sectors where the UK is already strong and there’s potential for faster growth: Advanced Manufacturing, Clean Energy Industries, Creative Industries, Defence, Digital and Technologies, Financial Services, Life Sciences, and Professional and Business Services.

Joint statement from business groups:

“The Industrial Strategy launched today marks a significant step forward and a valuable opportunity for the business community to rally behind a new vision for the UK—boosting confidence, sentiment, and enthusiasm for investment.

“From start-ups and small businesses to large corporates, businesses need a more attractive, stable environment that enables faster, easier, and more certain investment decisions.

“We welcome the Government’s engagement with businesses across the UK. Much of what we’ve shared has been heard and reflected in this strategy. While there’s more to do, we are ready to support the next steps.

“We encourage businesses nationwide to get behind this strategy and champion the UK as the best place to live, work, invest, and do business.”

Statement on behalf of:

Shevaun Haviland, Director General, British Chambers of Commerce

Rain Newton-Smith, Director General, Confederation of British Industry

Aaron Asadi, Chief Executive Officer, Enterprise Nation

Tina McKenzie, Policy and Advocacy Chair, Federation of Small Businesses

Stephen Phipson, Chief Executive Officer, Make UK

Michelle Ovens, Founder, Small Business Britain

Dom Hallas, Executive Director, Startup Coalition

Advanced Manufacturing

Dr Hayaatun Sillem CBE, Chief Executive, Royal Academy of Engineering:

“We are delighted to see the announcement of new skills packages for tech, engineering and defence, recognising that the Industrial Strategy’s objectives simply cannot be delivered without a significant boost to investment in our engineering and tech talent base. These packages provide a much-needed opportunity for government to take a holistic view of the rapidly changing skills landscape, and to work with partners across industry and professional bodies to make sure the UK tackles its longstanding skills and diversity deficits in these crucial areas. Today is International Women in Engineering Day – a reminder that we still have much to do to deliver equitable participation in these high-value jobs, and better outcomes for people from all parts of the UK.

“The Royal Academy of Engineering looks forward to supporting government in taking forward these recommendations, including through our new Skills Centre. We also welcome the publication of the Technology Adoption Review and hope that this will result in meaningful action to increase the capacity of the UK’s industrial base and public sector to deploy existing technologies at the scale and pace demanded in today’s tech-driven world.”

John Harrison, General Counsel and Head of Public Affairs, Airbus:

“Airbus welcomes the UK’s modern Industrial Strategy. Having worked closely with the Government to help shape this plan, we are delighted to see it deliver a long-term vision, built on a genuine partnership with industry.

“The firm long-term commitment to the full innovation lifecycle, from R&D in the Aerospace Technology Institute to a focus on commercialisation and supply chain resilience, provides the confidence and stability needed to fuel innovation and anchor high-value manufacturing in the UK for decades to come. The significant new investment in skills is also critical, creating a strong pipeline of engineering and digital talent, which will be the foundation for developing the sustainable technologies of the future, from hydrogen-powered aircraft to next-generation space systems. We stand ready to help turn this ambitious strategy into a reality for British industry.”

Clean Energy

Dhara Vyas, CEO, Energy UK:

“Energy UK welcomes the Government’s new Industrial Strategy and Clean Energy Industries sector plan, which rightly recognise the pivotal role energy will play across the whole economy, powering growth through digitalisation and electrification, boosting regional prosperity and delivering economic security and resilience.  

“Stable, affordable energy prices will help ensure that the UK remains a competitive place to do business, and in an increasingly uncertain global operating environment, clean power will deliver energy security. Focussing on priority technologies where the UK has global expertise will deliver a strong competitive advantage for our businesses and economy.  

“We know the investment necessary to decarbonise the economy will mostly be funded by the private sector. Clarity on Government policy, removal of the barriers to investment and targeted support are all essential to meet this ambition.”    

Sue Ferns, Senior Deputy General Secretary, Prospect Union: 

“Boosting clean energy is not only an important mission in its own right, it is central to the success of every other sector. It is welcome to see the government doubling down on this mission, focusing investment on key technologies like renewables and nuclear energy, and recognising the key role that trade unions play as partners in this strategy. 

“Securing the investment is important, but perhaps the biggest challenge in this area is around the workforce. The energy workforce is undergoing an unprecedented transition, which creates opportunities for many but also serious challenges that need to be addressed. 

“Delivering on this strategy in a way which creates prosperity and supports jobs will require the government’s forthcoming energy workforce plan to be as ambitious as possible and fully backed by all parts of government.” 

Martin Pibworth, Chief Executive Designate, SSE plc:

“The government’s industrial strategy is a welcome signal of long-term thinking and ambition – doubling down on homegrown energy is the right thing for security, resilience and affordability, making the most of the UK’s competitive geographical and technical advantages in renewables in particular. It’s exactly the kind of commitment that gives industry the confidence to deliver at pace and scale, and with important decisions on energy policy expected in the weeks ahead, we hope to see a continued focus on unlocking investment that drives growth. As the UK’s clean energy champion, SSE is investing £17.5bn over five years to 2027 – building the infrastructure, creating high-quality jobs, supporting the supply chain and driving the innovation needed to deliver a net zero economy.”

Creative Industries

Caroline Norbury, Chief Executive, Creative UK:

“The Sector Plan signals that the creative industries are central to the UK’s growth story. From freelancers to scale-ups, this is a step towards the joined-up support our sector needs – and Creative UK stands ready to work with government and industry partners to turn ambition into action. 

“As we move into delivery mode, it’s essential that all parts of the sector – from cultural organisations to creative tech firms – are empowered to grow, invest and contribute fully to the UK’s economic future.”

Dana Strong, Sky Group CEO:

“We warmly welcome the Government’s support for the UK’s creative industries in today’s Industrial Strategy. The media and entertainment sector is a cultural powerhouse and a key driver of growth, with the potential to add £10 billion to the economy and create 40,000 jobs by 2033. Seizing this opportunity is vital to maintaining the UK’s global leadership in creativity.”

Alison Lomax, Managing Director, YouTube UK & Ireland: 

“We welcome the Creative Industries Sector Plan’s commitment to a robust framework for creatives across the UK. It’s particularly encouraging to see the government acknowledge the digital creator economy’s vital role in driving growth for our creative industries. By embracing new distribution models that boost our cultural exports, this vision will solidify the UK’s position as a global cultural superpower.”

Defence

David Lockwood OBE, CEO, Babcock International:

“We welcome the release of the Government’s Modern Industrial Strategy today, setting out the strategic direction for critical sectors including advanced manufacturing, space and nuclear. The Government’s intent to back British businesses and invest in sovereign industries will lay the foundations for economic growth and unleash the potential of the growth sectors to drive prosperity across the UK. We look forward to the publication of the Defence Sector Plan, and working with the Government to bolster the British defence industrial base and safeguard our national and economic security.”

Charles Woodburn, Chief Executive, BAE Systems:

“The UK’s modern Industrial Strategy rightly recognises the importance of investing in skills and developing a workforce for the future. The UK’s defence sector is a powerhouse of skilled employment and training. Across the supply chain, it’s critical that we continue to invest in our people, just as much as we invest in technology, to ensure we can deliver the capabilities our armed forces need to stay ahead in an era of increasing instability.

“That’s why, this year alone, BAE Systems is recruiting more than 2,400 new apprentices and graduates across the UK and we recognise the importance of government, industry and academia working together to develop the talent needed to support this critical high growth sector.”

Paul Livingston CBE, Chief Executive, Lockheed Martin UK & NATO:

“Lockheed Martin welcomes publication of the UK government’s Modern Industrial Strategy and especially its identification of defence, space, and digital technologies as core areas for driving economic growth and expanding mutually beneficial international partnerships with the United States, NATO and their allies. With 28 facilities spanning the length and breadth of the country we’re committed to combining the best skills, expertise and technologies from the UK and the United States to boost capacity, sustain jobs and deliver economic benefits in both countries.”

Digital and Tech

Antony Walker, Deputy CEO, techUK:

“Today, the government has outlined welcome measures to boost confidence for the UK tech sector and the wider economy.

“techUK has long called for the Industrial Strategy to focus on strengthening the conditions for growth of the UK tech sector and accelerating the adoption of new technologies across the economy and public services.

“In an era of rapid technological change, the government must now work in true partnership with business to bolster investment and digital adoption across the whole of the UK economy and secure the country’s competitive advantage in key markets, including semiconductors and AI. techUK, and our members, stand ready to support this government to do so.”

Allison Kirkby, Chief Executive, BT Group:

 “Long-term plans which have positive impact pay. 

“BT has invested over £24bn in the UK so far this decade and will invest a further £20bn before it’s done, to upgrade the country’s digital infrastructure.

“That’s why we welcome the Government’s Industrial Strategy for the decade ahead.

“And it’s great to see it give telecoms prominence: at the centre of a high-growth sector as well as a lever for growth in the wider economy. 

“We look forward to working more with Government on steps they can take to unlock further growth, and make sure the UK’s record-breaking fibre success story is followed fast by an acceleration in 5G too.”

Emily Turner, UK CEO, HSBC Innovation Banking:

“I welcome today’s Industrial Strategy, which sets out positive steps to back the UK’s growth driving sectors, particularly Digital and Technologies. This ten-year strategy will help position the UK as an open and attractive destination for talent and investment, at a time when global competition is particularly acute.  ”We look forward to working closely with our clients and the government to ensure the effective implementation of the sector plans to help realise the full ambition of the UK’s industrial strategy, while ensuring that it remains flexible to keep pace with technological developments.”

Darren Hardman, CEO, Microsoft UK:

“This is a really progressive plan from the Government. Cutting red tape, reducing energy costs, accelerating the delivery of new projects and ensuring the UK has a highly skilled workforce to take advantage of the AI economy. These are all critical factors in encouraging investment from businesses here in the UK and around the world.”

Vishal Marria, Founder and CEO, Quantexa:

“This Industrial Strategy is a key moment for the UK’s growth economy. By addressing structural headwinds like energy costs and grid access, the government is unlocking the potential of British industry. As a UK-founded data and AI company, we welcome the vision to make Britain the best place to build, scale, and invest. Lowering business electricity costs, accelerating clean energy, and prioritising digital skills are vital for sectors like technology, financial services, defence, and advanced manufacturing – all of which will rely on AI and trusted data to compete and lead. This strategy is the bold signal of confidence UK industry has been waiting for.”

Financial Services

Hannah Gurga, Director General, ABI: 

“Today’s Industrial Strategy delivers a clear long-term growth vision, commitment to genuine partnership with business and the regulatory certainty firms need to thrive. We’re pleased that financial services has been recognised as a key growth sector and look forward to working with government on the detailed sector plan.

“The expansion of the British Business Bank’s capacity and its new £6.6 billion growth-capital commitment will unlock vital funding to support smaller UK businesses and drive growth.”

Miles Celic OBE, Chief Executive Officer, TheCityUK:

“The ambitions of today’s Industrial Strategy are laudable, highlighting the priorities for national growth. Financial and related professional services are crucial to its success, from unlocking private capital for innovative businesses to increasing investible opportunities across the regions and nations.

“We believe that supporting growth across whole country is particularly important and we are pleased to see the establishment of the Strategic Investment Opportunities Unit within the Office for Investment. This is the first critical step in the proposal we’ve been pushing to attract investors and capital.

“Transforming both the planning and public procurement processes, making it easier for businesses to bring in global talent whilst addressing the skills shortfall here in the UK, and strengthening global market partnerships are vital for future proofing the economy and are steps where our industry has long called for action.

“The detailed delivery plans for each of the eight sectors of the Industrial Strategy will be critical to realising its ambition. We look forward to seeing these. The vital issue now is delivery. We are committed to working closely with government and the regulators on the successful execution of these ambitions.”

James Alexander, CEO, UKSIF:

“We welcome the overarching ambition of the Industrial Strategy, which feels like a generational shift in thinking. This rightly recognises that government and investors need to work in partnership through a shared vision so we can make the UK the ‘sustainable finance capital of the world’.”

Life Sciences

Richard Torbett, Chief Executive, ABPI:

“This strategy sets out a clear vision for how to grow the UK economy and is rightly focused on many of the key inputs the country needs to get right to create the conditions for success. The task now must be to move quickly from planning to delivery, rapidly boosting UK attractiveness for investment and returning the country to international competitiveness.   “For UK life sciences, a successful strategy means ensuring the UK is not only a cutting-edge place to research and develop the medicine of the future, but also a country which seeks to embrace and use the life-changing innovations we are developing. This will be the key litmus test for success in the upcoming life science sector plan and the NHS 10-year plan, where we hope to see more detail.”

Steve Bates OBE, CEO, UK BioIndustry Association (BIA):

 “The Industrial Strategy has prioritised the life sciences sector because it will disproportionately drive economic growth over the next decade and help deliver an NHS fit for the future.

“SMEs are the lifeblood of this innovative industry and a strength of the UK ecosystem, securing £3.7 billion investment last year, much of it from overseas. We are on the verge of creating a new generation of globally-impactful companies, so it is a smart move by Government to establish a dedicated support service to help 10–20 high-potential UK life science companies scale, attract investment, and remain headquartered in the UK.

“The £4 billion British Business Bank Industrial Strategy Growth Capital initiative will bring new agility to support fledgling companies and cutting-edge technologies as part of the pro-innovation Industrial Strategy. We look forward to working closely with the Bank as they establish this programme for our sector.

“These, alongside improved health data resources for innovators, faster clinical trials, more streamlined and joined-up medicines regulation and access pathways, and investments in medicines manufacturing, mean this Industrial Strategy and the upcoming Life Sciences Sector Plan deliver across the breadth of BIA’s priorities on behalf of our members. These plans are just the beginning, however, as we will now get down to the serious work of delivering these commitments in partnership with the Government.”

Professor Andrew Morris CBE FRSE PMedSci, President, Academy of Medical Sciences:

“Today’s Industrial Strategy represents a significant step forward for UK life sciences – placing the sector at the heart of our economic future and recognising health and wealth are inseparable. This bold vision acknowledges what the Academy of Medical Sciences has long argued: that our world-leading research institutions, the NHS and our exceptional scientific talent can drive national and regional renewal in ways no other sector can match. 

“We are particularly encouraged by the Government’s ambitious goal to make the UK the leading life sciences economy in Europe by 2030, and the third most important globally by 2035. This scale of ambition, combined with over £2bn of committed funding, demonstrates the recognition that life sciences uniquely delivers both economic prosperity and improved health outcomes for all.  

“The strategy’s focus on pillars for the life sciences – supporting world-class R&D, making the UK an outstanding place to start and grow life sciences businesses, and driving health innovation through NHS reform – provides the framework needed to unlock the sector’s full potential. We welcome the commitment to continue investing in discovery research alongside applied sciences, ensuring we maintain curiosity-driven research that underpins future breakthroughs. 

“Alignment with the forthcoming NHS 10-Year Health Plan offers unprecedented opportunity to ensure that cutting-edge innovations deliver rapid benefits for patients whilst driving economic growth. We look forward to the detailed life sciences sector plan that will translate these ambitions into action, and will continue working with Government to deliver this vision where scientific excellence drives both patient benefit and national prosperity as the UK achieves its full potential as a global leader in life sciences.”  

Professional and Business Services

Malcolm Gomersall, CEO, Grant Thornton UK:

“The publication of the Industrial Strategy is a welcome step forward in setting out a clear, long-term path for growth in the sectors that are powering our economy.

“The strategy and the Professional and Business Services plan reflect our own investment priorities for the future, such as increased tech and AI adoption, fostering a highly skilled workforce in areas such as cyber security, digital and net zero transition and growing our specialist capabilities which support the expansion of our clients into international markets. I welcome the clear intention that the wider sector deliver this strategy in partnership with the Government through the Professional and Business Services Council.

“As an employer of over 5,500 people in one UK’s fastest growing and most resilient sectors, ourown journey and track record over recent years has been remarkable. To achieve our ambitious growth plans, we know that we need to continue investing in the future, which means ensuring our people have the right skills and tools for a new era of business.”

Jon Holt, Group Chief Executive and UK Senior Partner, KPMG:

“The UK is the second-largest exporter of professional and business services, making our industry central to this country’s economic strength. We are at the forefront of the AI revolution, we are major employers of diverse talent and we support businesses of all sizes across the country. As a global success story it’s only right that we’re recognised as a high growth sector.

“This industrial strategy makes bold choices and sets clear priorities. Its impact will come from a genuine partnership between Government and business, working together on wins to really unlock the growth, profitability and investment that will shape the UK’s future.”

Rachel Taylor, Government and Health Industries Leader, PwC:

“An industrial strategy without business is just a wish list. The UK Government’s new strategy sets a welcome direction – and business stands ready to turn ambition into action.

“Skills are the new growth currency. The Strategy sets out a bold plan to close the UK’s skills gap, and this will make important steps in addressing business leaders’ concerns that we are losing top talent to other countries. We must work together – government, business and our world-class education institutions – to build the workforce of the future and keep that talent here.

“Business is ready to lean in. With the right framework, we can unlock investment, drive innovation and deliver the growth and opportunity this strategy sets out to achieve.”

Share this page

The following links open in a new tab

Share on Facebook (opens in new tab)

Share on Twitter (opens in new tab)

Updates to this page

Published 23 June 2025
MIL OSI United Kingdom –
June 24, 2025
MIL-OSI United Kingdom: Lord Mayor pays tribute to the Windrush generation | Westminster City Council

Source: City of Westminster

The significant role of the Windrush generation in getting a post-war Britain “back on its feet again” was highlighted by the Lord Mayor of Westminster as he paid tribute to the Caribbeans who have contributed to Westminster’s success.

The Lord Mayor, Cllr Paul Dimoldenberg, cited the compelling stories of the estimated 500,000 people who answered the call to come to 1950s Britain and rebuild a country exhausted by war.

Speaking on Windrush Day (June 22) at Westbourne Forum summer festival, the Lord Mayor said:

So essential was the Windrush generation to our economic recovery, that in the 1950s the NHS, British Rail, and the public transport industry were recruiting almost exclusively from the Caribbean. Our City and our country would be in a much worse state without their work.

“But their contribution goes far beyond simply their labour. They have helped build our communities, enriched our culture, and made Westminster a better place to live.”

The Lord Mayor highlighted individual contributions like that of Jamaican-born Gwendolyn Dennis who came to Westminster aged 26 and worked in both St Thomas’s Hospital and the Royal Orthopaedic Hospital, and Barbadian Levi Decourcey Husbands who moved to Maida Vale, and worked as a British Rail train guard. That legacy continues to this day with Gwendolyn’s granddaughter and Levi’s daughter both working for Westminster City Council, the Lord Mayor added.

This year’s Westbourne Forum festival was dedicated to celebrating the contribution the Windrush generation and their descendants have made not just in employment but also in culture, the arts and the wider community.

However, the Lord Mayor also made clear there was a darker aspect of that history that needed to noted:

We must acknowledge the challenges these people faced when they arrived. How much harder they had to work to overcome barriers that were placed in their way because of the prevailing atmosphere of racism, prejudice, and discrimination. These are issues that have never entirely gone away, and which we must keep working tirelessly to eliminate.”

The Lord Mayor concluded:

We are proud to continue working towards a unity of people across spectrums, building a better, fairer Westminster, and recognising that the Windrush generation and their legacy can help to bridge the divides in our society.”

MIL OSI United Kingdom –

June 24, 2025
MIL-OSI Canada: Construction begins on operating rooms at Vancouver General Hospital
Source: Government of Canada regional news

New operating rooms at Vancouver General Hospital will provide people in Vancouver and throughout British Columbia with better access to faster, high-quality surgical care.

Construction has begun on 15 new operating rooms and one hybrid operating room upgrade as part of Phase 2 of the operating-room expansion at Vancouver General Hospital. Completion of both phases of the operating-room expansion is expected to increase the number of surgeries from 16,800 to more than 19,000 per year.

“These new universal operating rooms will substantially increase the number of surgeries that can be delivered from Vancouver General Hospital,” said Bowinn Ma, Minister of Infrastructure. “Construction is now underway on these important health-care facilities, while also creating good jobs during construction and, once complete, in health care.”

The new operating rooms will have a universal design, allowing any surgery to be performed in any room. They will be built to better accommodate equipment and storage, supporting a logical flow of tasks and activities during surgeries and improving efficiency. The enhanced design, technology and equipment will create a safer, more comfortable working environment for all staff and will optimize patient safety and surgical outcomes.

“Our team at Vancouver General Hospital is continuously adopting cutting-edge techniques and technologies to achieve the best results for our patients,” said Dr. Kelly Lefaivre, a surgeon in the orthopedic trauma division at Vancouver General and UBC Hospitals. “These new, innovative operating rooms provide a state-of-the-art surgical environment so we can continue to push boundaries, advance surgical medicine and care for the most complex patient cases in British Columbia.”

In May 2021, Phase 1 of the project was completed with the opening of the Phil and Jennie Gaglardi Surgical Centre, featuring 16 advanced operating rooms and a 40-bay pre- and post-operative recovery area. Once phase 2 is finished, the surgical centre will have 32 operating rooms and 78 perioperative bays, along with upgraded infrastructure, including heating, ventilation, air conditioning (HVAC), electrical and plumbing systems. With these new, flexible operating rooms, health-care teams will be able to increase the number of operating room hours available and surgeries performed.

“For people who’ve been waiting for surgery, this much-needed expansion builds on the work we’ve been doing to enhance care around B.C.,” said Josie Osborne, Minister of Health. “Whether it’s a senior waiting to walk pain-free again or the parent hoping to return to work after surgery, this project means thousands more people each year will get the surgery they need, faster.”

Vancouver General Hospital is a tertiary care site, providing a full range of acute and specialized health-care services for patients from across the Lower Mainland and throughout British Columbia. It provides specialized provincial programming for solid organ transplant, spinal-cord injury, trauma, burns and neurosurgery, as well as robotic and complex general surgery.

The operating-room renewal project is funded by the Province of British Columbia and VGH & UBC Hospital Foundation.

Quotes:

Brenda Bailey, MLA for Vancouver-South Granville –

“This is great news for the community. Adding new operating rooms means people in Vancouver and from nearby can get surgery faster. This investment will help reduce wait times, so more patients get the care they need sooner, saving lives. It will help build a stronger health system that delivers better care for everyone.”

Vivian Eliopoulos, president and CEO, Vancouver Coastal Health –

“Increasing the operating-room capacity at Vancouver General Hospital benefits patients from Vancouver Coastal Health and across our province, ensuring they receive timely access to surgical procedures. Our larger, universally designed operating rooms will support all our staff by increasing efficiencies, providing a safer and more comfortable working environment and enabling them to do their best work so they can optimize patient safety and outcomes.”

Angela Chapman, president and chief operating officer, VGH & UBC Hospital Foundation –

“We are deeply grateful to our community of donors who gave generously to the Future of Surgery campaign to expand and improve surgical capacity at Vancouver General Hospital and UBC Hospital. Their continued support ensures that our health-care teams have the cutting-edge spaces, tools and technologies they need to deliver the highest standard of care. Philanthropy has been the catalyst to transform these spaces and improve surgical care, contributing to healthier lives for healthier communities in B.C.”

Quick Facts:
- The new operating rooms will be built on level 2 of the Jim Pattison Pavilion at Vancouver General Hospital at 899 W. 12th Ave.
- Construction is expected to finish in 2029.
- Once this phase is complete, the Phil and Jennie Gaglardi Surgical Centre will have 32 operating rooms located on levels 2 and 3.
- The project will create approximately 1,800 direct and 500 indirect jobs.
Learn More:

To read about Phase 1 of this project, visit: https://news.gov.bc.ca/releases/2022HLTH0142-000763

For more information about health capital projects in B.C., visit: https://www2.gov.bc.ca/gov/content/health/accessing-health-care/capital-projects

MIL OSI Canada News –
June 24, 2025